Selection	O
and	O
long-term	O
persistence	O
of	O
reactive	O
CTL	B-cell_line
clones	I-cell_line
during	O
an	O
EBV	O
chronic	O
response	O
are	O
determined	O
by	O
avidity	O
,	O
CD8	B-protein
variable	O
contribution	O
compensating	O
for	O
differences	O
in	O
TCR	B-protein
affinities	O
.	O

Recent	O
studies	O
have	O
suggested	O
that	O
the	O
diversity	O
of	O
TCR	B-protein
repertoire	O
after	O
primary	O
immunization	O
is	O
conserved	O
in	O
memory	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
that	O
a	O
progressive	O
narrowing	O
of	O
this	O
repertoire	O
may	O
take	O
place	O
during	O
recall	O
infections	O
.	O

It	O
now	O
remains	O
to	O
be	O
investigated	O
which	O
parameters	O
determine	O
the	O
repertoire	O
of	O
the	O
memory	O
response	O
and	O
possibly	O
restrict	O
its	O
diversity	O
after	O
subsequent	O
antigenic	O
challenges	O
.	O

To	O
address	O
this	O
question	O
,	O
we	O
took	O
advantage	O
of	O
a	O
panel	O
of	O
CD8+	B-cell_line
T	I-cell_line
cell	I-cell_line
clones	I-cell_line
from	O
the	O
joint	O
of	O
a	O
rheumatoid	O
arthritis	O
patient	O
and	O
selected	O
for	O
their	O
reactivity	O
against	O
a	O
single	B-protein
MHC/peptide	I-protein
complex	I-protein
.	O

Characterization	O
of	O
both	O
TCR	B-protein
chains	I-protein
documented	O
a	O
great	O
diversity	O
among	O
those	O
clones	O
and	O
the	O
persistence	O
of	O
clonotypes	O
over	O
a	O
2-yr	O
period	O
.	O

Strikingly	O
,	O
despite	O
the	O
observed	O
repertoire	O
heterogeneity	O
,	O
all	O
clones	O
displayed	O
a	O
narrow	O
range	O
of	O
MHC	B-protein
/peptide	O
density	O
requirements	O
in	O
cytotoxicity	O
assays	O
(	O
ED50	O
between	O
9	O
and	O
36	O
nM	O
)	O
.	O

TCR	B-protein
affinities	O
were	O
then	O
indirectly	O
estimated	O
by	O
blocking	O
CD8	B-protein
interaction	O
with	O
an	O
anti-CD8	B-protein
mAb	I-protein
.	O

We	O
found	O
a	O
wide	O
range	O
of	O
TCR	B-protein
affinities	O
among	O
the	O
different	O
clonotypes	O
that	O
segregated	O
with	O
Vbeta	O
usage	O
.	O

We	O
thus	O
propose	O
that	O
during	O
an	O
in	O
vivo	O
chronic	O
response	O
,	O
a	O
narrow	O
range	O
of	O
avidity	O
of	O
the	O
TCR-CD8	B-protein
complex	I-protein
conditions	O
long-term	O
clonotype	O
persistence	O
,	O
and	O
that	O
the	O
level	O
of	O
CD8	B-protein
contribution	O
is	O
adjusted	O
to	O
keep	O
clonotypes	O
with	O
variable	O
TCR	B-protein
affinities	O
within	O
this	O
avidity	O
window	O
.	O

'_9	NULL
Analytes	NULL
=	NULL
Comprehensive	NULL
Analysis	NULL
n	NULL
MICFOVUG	NULL
Wim	NULL
Ba	NULL
,	NULL
Bb	NULL
,	NULL
C3a	NULL
,	NULL
C4a	NULL
,	NULL
C4d	NULL
,	NULL
CSa	NULL
,	NULL
s	NULL
SCS5b-9	NULL
,	NULL
Factor	NULL
H	NULL
,	NULL
Factor	NULL
|	NULL
QUIpEL	NULL
MULTIPLEX	NULL
I	NULL
ill	NULL
``	NULL
``	NULL
A	NULL
SE	NULL
ANTS	NULL
ty	NULL
ay	NULL
Sa	NULL
meJournal	NULL
of	NULL
Selection	NULL
and	NULL
Long-Term	NULL
Persistence	NULL
of	NULL
C	NULL
Immunolo	NULL
gy	NULL
Reactive	NULL
CTL	NULL
Clones	NULL
During	NULL
an	NULL
EBV	NULL
Chronic	NULL
Response	NULL
Are	NULL
Determined	NULL
by	NULL
10	NULL
,	NULL
2	NULL
,	NULL
Avidity	NULL
,	NULL
CD8	NULL
Variable	NULL
Contribution	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
_	NULL
Compensating	NULL
for	NULL
Differences	NULL
in	NULL
TCR	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Affinities	NULL
Chrystelle	NULL
Couedel	NULL
,	NULL
Marie	NULL
Bodinier	NULL
,	NULL
Marie-Alix	NULL
Peyrat	NULL
,	NULL
Marc	NULL
Bonneville	NULL
,	NULL
Frangois	NULL
Davodeau	NULL
and	NULL
Frangois	NULL
Lang	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:6351-6358	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/11/6351	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
37	NULL
articles	NULL
,	NULL
20	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/11/6351	NULL
full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Selection	NULL
and	NULL
Long-Term	NULL
Persistence	NULL
of	NULL
Reactive	NULL
CTL	NULL
Clones	NULL
During	NULL
an	NULL
EBV	NULL
Chronic	NULL
Response	NULL
Are	NULL
Determined	NULL
by	NULL
Avidity	NULL
,	NULL
CD8	NULL
Variable	NULL
Contribution	NULL
Compensating	NULL
for	NULL
Differences	NULL
in	NULL
TCR	NULL
Affinities	NULL
'	NULL
Chrystelle	NULL
Couedel	NULL
,	NULL
**	NULL
Marie	NULL
Bodinier	NULL
,	NULL
``	NULL
*	NULL
Marie-Alix	NULL
Peyrat	NULL
,	NULL
*	NULL
Marc	NULL
Bonneville	NULL
,	NULL
*	NULL
Francois	NULL
Davodeau	NULL
,	NULL
``	NULL
*	NULL
and	NULL
Francois	NULL
Lang**	NULL
Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
diversity	NULL
of	NULL
TCR	NULL
repertoire	NULL
after	NULL
primary	NULL
immunization	NULL
is	NULL
conserved	NULL
in	NULL
memory	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
a	NULL
progressive	NULL
narrowing	NULL
of	NULL
this	NULL
repertoire	NULL
may	NULL
take	NULL
place	NULL
during	NULL
recall	NULL
infections	NULL
.	NULL

It	NULL
now	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
which	NULL
parameters	NULL
determine	NULL
the	NULL
repertoire	NULL
of	NULL
the	NULL
memory	NULL
response	NULL
and	NULL
possibly	NULL
restrict	NULL
its	NULL
diversity	NULL
after	NULL
subsequent	NULL
antigenic	NULL
challenges	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
we	NULL
took	NULL
advantage	NULL
of	NULL
a	NULL
panel	NULL
of	NULL
CD8	NULL
*	NULL
T	NULL
cell	NULL
clones	NULL
from	NULL
the	NULL
joint	NULL
of	NULL
a	NULL
rheumatoid	NULL
arthritis	NULL
patient	NULL
and	NULL
selected	NULL
for	NULL
their	NULL
reactivity	NULL
against	NULL
a	NULL
single	NULL
MHC/peptide	NULL
complex	NULL
.	NULL

Characterization	NULL
of	NULL
both	NULL
TCR	NULL
chains	NULL
documented	NULL
a	NULL
great	NULL
diversity	NULL
among	NULL
those	NULL
clones	NULL
and	NULL
the	NULL
persistence	NULL
of	NULL
clonotypes	NULL
over	NULL
a	NULL
2-yr	NULL
period	NULL
.	NULL

Strikingly	NULL
,	NULL
despite	NULL
the	NULL
observed	NULL
repertoire	NULL
heterogeneity	NULL
,	NULL
all	NULL
clones	NULL
displayed	NULL
a	NULL
narrow	NULL
range	NULL
of	NULL
MHC/peptide	NULL
density	NULL
requirements	NULL
in	NULL
cytotoxicity	NULL
assays	NULL
(	NULL
ED	NULL
;	NULL
,	NULL
between	NULL
9	NULL
and	NULL
36	NULL
nM	NULL
)	NULL
.	NULL

TCR	NULL
affinities	NULL
were	NULL
then	NULL
indirectly	NULL
estimated	NULL
by	NULL
blocking	NULL
CD8	NULL
interaction	NULL
with	NULL
an	NULL
anti-CD8	NULL
mAb	NULL
.	NULL

We	NULL
found	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
TCR	NULL
affinities	NULL
among	NULL
the	NULL
different	NULL
clonotypes	NULL
that	NULL
segregated	NULL
with	NULL
VB	NULL
usage	NULL
.	NULL

We	NULL
thus	NULL
propose	NULL
that	NULL
during	NULL
an	NULL
in	NULL
vivo	NULL
chronic	NULL
response	NULL
,	NULL
a	NULL
narrow	NULL
range	NULL
of	NULL
avidity	NULL
of	NULL
the	NULL
TCR-CD8	NULL
complex	NULL
conditions	NULL
long-term	NULL
clonotype	NULL
persistence	NULL
,	NULL
and	NULL
that	NULL
the	NULL
level	NULL
of	NULL
CD8	NULL
contribution	NULL
is	NULL
adjusted	NULL
to	NULL
keep	NULL
clonotypes	NULL
with	NULL
variable	NULL
TCR	NULL
affinities	NULL
within	NULL
this	NULL
avidity	NULL
window	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
6351-6358.	NULL
he	NULL
essential	NULL
role	NULL
of	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
is	NULL
the	NULL
recognition	NULL
and	NULL
lysis	NULL
of	NULL
virally	NULL
infected	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

This	NULL
recognition	NULL
of	NULL
an	NULL
immunogenic	NULL
viral	NULL
epitope	NULL
presented	NULL
by	NULL
a	NULL
class	NULL
I	NULL
MHC	NULL
molecule	NULL
imposes	NULL
the	NULL
selection	NULL
of	NULL
a	NULL
restricted	NULL
set	NULL
of	NULL
T	NULL
cells	NULL
whose	NULL
TCRs	NULL
are	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
MHC/peptide	NULL
complex	NULL
with	NULL
sufficient	NULL
affinity	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
numerous	NULL
studies	NULL
have	NULL
demonstrated	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
stringent	NULL
selection	NULL
process	NULL
among	NULL
reactive	NULL
T	NULL
cell	NULL
clones	NULL
leading	NULL
to	NULL
conserved	NULL
TCR	NULL
structural	NULL
features	NULL
at	NULL
the	NULL
combinatorial	NULL
and/or	NULL
junctional	NULL
levels	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
recent	NULL
years	NULL
,	NULL
molecular	NULL
characterization	NULL
of	NULL
immunogenic	NULL
peptides	NULL
and	NULL
their	NULL
MHC-restrict-ing	NULL
elements	NULL
has	NULL
allowed	NULL
to	NULL
directly	NULL
analyze	NULL
the	NULL
responsive	NULL
T	NULL
cell	NULL
populations	NULL
against	NULL
a	NULL
given	NULL
MHC/peptide	NULL
complex	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
demonstrated	NULL
that	NULL
aside	NULL
from	NULL
the	NULL
expected	NULL
homogeneity	NULL
of	NULL
TCR	NULL
features	NULL
seen	NULL
in	NULL
some	NULL
T	NULL
cell	NULL
responses	NULL
,	NULL
other	NULL
responses	NULL
involved	NULL
diverse	NULL
T	NULL
cell	NULL
populations	NULL
with	NULL
very	NULL
distinct	NULL
TCR	NULL
structures	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
number	NULL
of	NULL
recent	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
when	NULL
the	NULL
reactive	NULL
repertoire	NULL
seen	NULL
in	NULL
the	NULL
primary	NULL
response	NULL
was	NULL
diverse	NULL
(	NULL
as	NULL
assessed	NULL
by	NULL
VB	NULL
usage	NULL
)	NULL
,	NULL
this	NULL
diversity	NULL
was	NULL
maintained	NULL
after	NULL
in	NULL
vitro	NULL
reexposure	NULL
to	NULL
the	NULL
immunizing	NULL
peptide/MHC	NULL
complex	NULL
(	NULL
8-10	NULL
)	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
T	NULL
cells	NULL
with	NULL
distinct	NULL
TCR	NULL
affinities	NULL
can	NULL
*Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
U463	NULL
,	NULL
Institute	NULL
of	NULL
Biology	NULL
,	NULL
and	NULL
*Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
College	NULL
of	NULL
Pharmacy	NULL
,	NULL
Nantes	NULL
,	NULL
France	NULL
Received	NULL
for	NULL
publication	NULL
September	NULL
28	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
10	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
I	NULL
'	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
contre	NULL
le	NULL
Cancer	NULL
and	NULL
1	NULL
'	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
la	NULL
Polyarthrite	NULL
.	NULL

2	NULL
C.C	NULL
.	NULL

and	NULL
M.B	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

°	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Frangois	NULL
Davodeau	NULL
,	NULL
Institut	NULL
de	NULL
biologic	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
U4G63	NULL
,	NULL
9	NULL
quai	NULL
Moncousu	NULL
,	NULL
44093	NULL
Nantes	NULL
Cedex	NULL
01	NULL
,	NULL
France	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
davodeau	NULL
@	NULL
nantes.inserm.fr	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
enter	NULL
equally	NULL
well	NULL
the	NULL
memory	NULL
compartment	NULL
.	NULL

The	NULL
remaining	NULL
matter	NULL
of	NULL
debate	NULL
is	NULL
whether	NULL
the	NULL
recruitment	NULL
of	NULL
effectors	NULL
from	NULL
the	NULL
memory	NULL
pool	NULL
in	NULL
vivo	NULL
will	NULL
be	NULL
influenced	NULL
by	NULL
repetitive	NULL
Ag	NULL
reexposure	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
will	NULL
be	NULL
progressively	NULL
restricted	NULL
to	NULL
clones	NULL
with	NULL
particular	NULL
affinities/	NULL
avidities	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
in	NULL
patients	NULL
suffering	NULL
from	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
reactive	NULL
against	NULL
EBV	NULL
proteins	NULL
were	NULL
dramatically	NULL
amplified	NULL
in	NULL
synovial	NULL
fluid	NULL
compared	NULL
with	NULL
peripheral	NULL
blood	NULL
(	NULL
11	NULL
)	NULL
.	NULL

To	NULL
address	NULL
the	NULL
aforementioned	NULL
question	NULL
,	NULL
we	NULL
focused	NULL
our	NULL
analysis	NULL
on	NULL
one	NULL
patient	NULL
whose	NULL
response	NULL
was	NULL
predominantly	NULL
directed	NULL
toward	NULL
a	NULL
peptide	NULL
originated	NULL
from	NULL
the	NULL
EBV	NULL
trans-activator	NULL
BZLF1	NULL
presented	NULL
in	NULL
the	NULL
MHC	NULL
class	NULL
I	NULL
B4002	NULL
context	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
this	NULL
reactivity	NULL
could	NULL
account	NULL
for	NULL
most	NULL
of	NULL
the	NULL
observed	NULL
T	NULL
cell	NULL
subset	NULL
amplification	NULL
,	NULL
as	NULL
cell	NULL
lines	NULL
established	NULL
after	NULL
immunosorting	NULL
with	NULL
V	NULL
B-specific	NULL
Abs	NULL
were	NULL
reactive	NULL
against	NULL
this	NULL
particular	NULL
epitope	NULL
.	NULL

Twenty-seven	NULL
months	NULL
later	NULL
,	NULL
we	NULL
obtained	NULL
synovial	NULL
membrane-in-filtrating	NULL
lymphocytes	NULL
from	NULL
the	NULL
same	NULL
patient	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
by	NULL
cytofluorometric	NULL
analysis	NULL
that	NULL
VB	NULL
usage	NULL
among	NULL
joint-infiltrating	NULL
T	NULL
lymphocytes	NULL
from	NULL
this	NULL
patient	NULL
was	NULL
very	NULL
diverse	NULL
and	NULL
stable	NULL
over	NULL
time	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
structural	NULL
analysis	NULL
of	NULL
TCR	NULL
a-	NULL
and	NULL
B-chains	NULL
from	NULL
BZLF1-reactive	NULL
clones	NULL
obtained	NULL
from	NULL
both	NULL
samples	NULL
to	NULL
formally	NULL
document	NULL
the	NULL
diversity	NULL
of	NULL
the	NULL
responsive	NULL
population	NULL
and	NULL
to	NULL
look	NULL
for	NULL
possible	NULL
shared	NULL
features	NULL
between	NULL
the	NULL
different	NULL
TCR	NULL
used	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
took	NULL
advantage	NULL
of	NULL
this	NULL
very	NULL
diverse	NULL
repertoire	NULL
to	NULL
analyze	NULL
the	NULL
contribution	NULL
of	NULL
TCR	NULL
affini-ties/avidities	NULL
in	NULL
the	NULL
long-term	NULL
persistence	NULL
of	NULL
the	NULL
different	NULL
clono-types	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
despite	NULL
significant	NULL
differences	NULL
in	NULL
TCR	NULL
affinities	NULL
among	NULL
the	NULL
different	NULL
in	NULL
vivo	NULL
selected	NULL
clones	NULL
,	NULL
these	NULL
clones	NULL
displayed	NULL
very	NULL
comparable	NULL
MHC/peptide	NULL
density	NULL
requirements	NULL
due	NULL
to	NULL
a	NULL
variable	NULL
contribution	NULL
of	NULL
the	NULL
coreceptor	NULL
CD8	NULL
in	NULL
the	NULL
interaction	NULL
with	NULL
the	NULL
peptide/MHC	NULL
complex	NULL
,	NULL
thus	NULL
strongly	NULL
suggesting	NULL
that	NULL
avidity	NULL
and	NULL
not	NULL
affinity	NULL
is	NULL
the	NULL
critical	NULL
parameter	NULL
governing	NULL
long-term	NULL
clonotype	NULL
persistence	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6352	NULL
AVIDITY	NULL
,	NULL
NOT	NULL
TCR	NULL
AFFINITY	NULL
,	NULL
RULES	NULL
IN	NULL
VIVO	NULL
SELECTION	NULL
OF	NULL
EBV-REACTIVE	NULL
CTL	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Oligonucleotides	NULL
used	NULL
for	NULL
TCR-a	NULL
transcripts	NULL
analysis	NULL
Oligonucleotide	NULL
Oligonucleotide	NULL
Fragment	NULL
Set	NULL
Name	NULL
Sequence	NULL
Size	NULL
(	NULL
bp	NULL
)	NULL
Va	NULL
Specificity	NULL
I	NULL
A	NULL
YTTCCACCTGAAGAAACC	NULL
295	NULL
981,1681	NULL
I	NULL
R	NULL
AGTGGTCGGTATICTIGG	NULL
340	NULL
1281	NULL
I	NULL
T	NULL
CACATATGACACCAGTGA	NULL
440	NULL
681,1481,1482	NULL
I	NULL
L	NULL
TTGSTGATTITGIGGCTT	NULL
550	NULL
581,2481	NULL
II	NULL
K	NULL
WGMMGACAGAAAGTCCAG	NULL
310	NULL
451,482,2081	NULL
II	NULL
E	NULL
TTCGTTCAAATATGGACA	NULL
365	NULL
8S2	NULL
II	NULL
I	NULL
TRAACAATTTIRCAGTGGT	NULL
420	NULL
381,1381	NULL
II	NULL
M	NULL
CRGAAGGAGGTGGAGCAG	NULL
510	NULL
281,252,253	NULL
II	NULL
D	NULL
TGARAAAAAGCAGCAAAG	NULL
310	NULL
2681,2981	NULL
II	NULL
C	NULL
MAAYAAAAGTGCCAAGCA	NULL
315	NULL
1781,2181	NULL
II	NULL
H	NULL
TACCCTWCCCTTITCTIGG	NULL
420	NULL
2281,3181	NULL
II	NULL
P	NULL
WIGTYCASGAGGGAGACA	NULL
475	NULL
1581,1881,28S1	NULL
IV	NULL
B	NULL
TYYCTGCACATCACAGCC	NULL
295	NULL
1981,3081,3281	NULL
IV	NULL
O	NULL
GYTTIGAGGCTGAATTIA	NULL
330	NULL
181,182,183,184,185	NULL
IV	NULL
J	NULL
TACARGCAGGAYCCTGGG	NULL
410	NULL
1081,2381,2581,2781	NULL
IV	NULL
Q	NULL
TCAGCCTTCCACAGTGGC	NULL
480	NULL
1181	NULL
IV	NULL
N	NULL
CATGAAGATGGGAGGCAC	NULL
535	NULL
781,782	NULL
MM	NULL
D1	NULL
GGTCGCTATTCTGTICAACTIC	NULL
335	NULL
DV10181	NULL
MM	NULL
D3	NULL
GCTCTGCACTTACGACACTGT	NULL
340	NULL
DV103S1	NULL
MM	NULL
D2	NULL
CAGCCATIGAGTTGGTGCCTG	NULL
510	NULL
DV102S1	NULL
Materials	NULL
and	NULL
Methods	NULL
EBV-reactive	NULL
T	NULL
cell	NULL
clones	NULL
Lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
either	NULL
synovial	NULL
fluid	NULL
(	NULL
first	NULL
sample	NULL
)	NULL
or	NULL
synovial	NULL
membrane	NULL
(	NULL
second	NULL
sample	NULL
)	NULL
from	NULL
a	NULL
43-yr-old	NULL
woman	NULL
who	NULL
had	NULL
a	NULL
typical	NULL
rheumatoid	NULL
arthritis	NULL
lasting	NULL
for	NULL
6	NULL
yr	NULL
at	NULL
the	NULL
time	NULL
of	NULL
the	NULL
first	NULL
sample	NULL
collection	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Lymphocytes	NULL
from	NULL
the	NULL
first	NULL
sample	NULL
were	NULL
sorted	NULL
using	NULL
VB-specific	NULL
Abs	NULL
directed	NULL
against	NULL
the	NULL
subpopulations	NULL
that	NULL
were	NULL
overrepresented	NULL
in	NULL
the	NULL
inflamed	NULL
joint	NULL
as	NULL
compared	NULL
with	NULL
peripheral	NULL
blood	NULL
(	NULL
11	NULL
)	NULL
and	NULL
cloned	NULL
.	NULL

In	NULL
the	NULL
second	NULL
sample	NULL
,	NULL
all	NULL
CD8-positive	NULL
lymphocytes	NULL
from	NULL
the	NULL
synovial	NULL
membrane	NULL
were	NULL
sorted	NULL
out	NULL
and	NULL
randomly	NULL
cloned	NULL
.	NULL

Among	NULL
all	NULL
of	NULL
the	NULL
clones	NULL
reactive	NULL
against	NULL
EBV	NULL
proteins	NULL
,	NULL
only	NULL
those	NULL
reactive	NULL
against	NULL
the	NULL
BZLFI1	NULL
epitope	NULL
SENDRLRLL	NULL
presented	NULL
in	NULL
the	NULL
HLA-B4002	NULL
were	NULL
selected	NULL
for	NULL
the	NULL
present	NULL
study	NULL
.	NULL

These	NULL
clones	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
10	NULL
%	NULL
human	NULL
serum	NULL
supplemented	NULL
with	NULL
rIL-2	NULL
(	NULL
100	NULL
IU/ml	NULL
)	NULL
and	NULL
restimulated	NULL
every	NULL
6	NULL
wk	NULL
under	NULL
polyclonal	NULL
activation	NULL
(	NULL
irradiated	NULL
PBL	NULL
and	NULL
EBV-trans-formed	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
BLCL	NULL
)	NULL
,	NULL
*	NULL
leukoagglutinine	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
,	NULL
and	NULL
IL-2	NULL
)	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
clone	NULL
TCR	NULL
a	NULL
transcripts	NULL
RNA	NULL
from	NULL
5	NULL
X	NULL
10°	NULL
T	NULL
cell	NULL
clones	NULL
was	NULL
extracted	NULL
using	NULL
TRIzol	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
supplier	NULL
's	NULL
instructions	NULL
,	NULL
and	NULL
dissolved	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
40	NULL
pl	NULL
of	NULL
water	NULL
.	NULL

Reverse	NULL
transcription	NULL
was	NULL
performed	NULL
on	NULL
2.5	NULL
ul	NULL
of	NULL
the	NULL
RNA	NULL
solution	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
12.5	NULL
pl	NULL
for	NULL
30	NULL
min	NULL
at	NULL
45°C	NULL
in	NULL
a	NULL
mix	NULL
containing	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
75	NULL
mM	NULL
KCI	NULL
,	NULL
3	NULL
mM	NULL
Mg	NULL
Cl	NULL
;	NULL
,	NULL
10	NULL
mM	NULL
DTT	NULL
,	NULL
10	NULL
U	NULL
rRNasin	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WD	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
each	NULL
dNTP	NULL
,	NULL
100	NULL
U	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
(	NULL
M-MLV	NULL
)	NULL
reverse	NULL
Sequences	NULL
were	NULL
conducted	NULL
on	NULL
purified	NULL
PCR	NULL
product	NULL
with	NULL
Sequenase	NULL
(	NULL
Amersham	NULL
)	NULL
with	NULL
a	NULL
modified	NULL
supplier	NULL
's	NULL
protocol	NULL
.	NULL

Denaturation	NULL
and	NULL
annealing	NULL
step	NULL
were	NULL
performed	NULL
by	NULL
heating	NULL
at	NULL
95°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
cooling	NULL
immediately	NULL
on	NULL
ice	NULL
ethanol	NULL
.	NULL

For	NULL
labeling	NULL
,	NULL
we	NULL
used	NULL
a	NULL
sequencing	NULL
primer	NULL
,	NULL
positioned	NULL
just	NULL
in	NULL
front	NULL
of	NULL
a	NULL
sequence	NULL
rich	NULL
in	NULL
T	NULL
,	NULL
but	NULL
lacking	NULL
G	NULL
to	NULL
force	NULL
incorporation	NULL
of	NULL
adenosine	NULL
*°S	NULL
using	NULL
dCTP	NULL
,	NULL
dTTP	NULL
,	NULL
dATP	NULL
labeling	NULL
mix	NULL
,	NULL
and	NULL
to	NULL
limit	NULL
elongation	NULL
at	NULL
the	NULL
first	NULL
C	NULL
encountered	NULL
on	NULL
the	NULL
C	NULL
``	NULL
sequence	NULL
.	NULL

Analysis	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
clone	NULL
TCR	NULL
B	NULL
transcripts	NULL
Reverse	NULL
transcription	NULL
was	NULL
conducted	NULL
using	NULL
a	NULL
CI	NULL
reverse	NULL
primer	NULL
(	NULL
5-GCA	NULL
GACAGGACCCCTTGCTGG-3	NULL
'	NULL
)	NULL
specific	NULL
for	NULL
both	NULL
CBI	NULL
and	NULL
CB2	NULL
C	NULL
region	NULL
gene	NULL
,	NULL
in	NULL
the	NULL
conditions	NULL
described	NULL
for	NULL
C-specific	NULL
reverse	NULL
transcription	NULL
.	NULL

Reverse	NULL
transcription	NULL
was	NULL
completed	NULL
to	NULL
50	NULL
pl	NULL
with	NULL
1X	NULL
mix	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
(	NULL
Pharmacia	NULL
)	NULL
(	NULL
10	NULL
mM	NULL
Tris-HC	NULL
]	NULL
(	NULL
pH	NULL
9	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1.5	NULL
mM	NULL
Mg	NULL
Cl	NULL
;	NULL
)	NULL
;	NULL
1.25	NULL
U	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
;	NULL
and	NULL
12.5	NULL
pM	NULL
of	NULL
each	NULL
degenerated	NULL
primer	NULL
,	NULL
VBA	NULL
,	NULL
5'-CAYNRVDMYRTBTMYTGGTA-3	NULL
'	NULL
,	NULL
and	NULL
VBB	NULL
,	NULL
5'-CMYRMHMMYMTKTWYTGGTA-3	NULL
'	NULL
.	NULL

A	NULL
first	NULL
amplification	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
96-well	NULL
thermocycler	NULL
(	NULL
PTC-100	NULL
;	NULL
MJ	NULL
Research	NULL
)	NULL
with	NULL
the	NULL
following	NULL
cycle	NULL
:	NULL
5	NULL
%	NULL
(	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
55°C	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
5	NULL
%	NULL
X	NULL
(	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
50°C	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
5	NULL
%	NULL
(	NULL
94°C	NULL
for	NULL
Table	NULL
II	NULL
.	NULL

-	NULL
Avidifies	NULL
of	NULL
the	NULL
different	NULL
clonotypes	NULL
for	NULL
their	NULL
targets	NULL
and	NULL
contribution	NULL
of	NULL
the	NULL
CD8	NULL
coreceptor	NULL
``	NULL
EDs	NULL
,	NULL
(	NULL
nM	NULL
transcriptase	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
and	NULL
25	NULL
pM	NULL
C*-specific	NULL
reverse	NULL
primer	NULL
so	NULL
CM	NULL
5'-TGAAGTCCATAGACCTCATGTC-3	NULL
'	NULL
.	NULL

For	NULL
each	NULL
clone	NULL
,	NULL
five	NULL
reverse	NULL
Clones	NULL
Without	NULL
anti-CD8	NULL
With	NULL
anti-CD8	NULL
Ratio	NULL
transcriptions	NULL
were	NULL
performed	NULL
(	NULL
one	NULL
for	NULL
each	NULL
multiplex	NULL
PCR	NULL
)	NULL
.	NULL

Each	NULL
reverse	NULL
transcription	NULL
was	NULL
completed	NULL
to	NULL
50	NULL
pl	NULL
with	NULL
1X	NULL
mix	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
6.1	NULL
35.4	NULL
+	NULL
2.0	NULL
50.9	NULL
+	NULL
5.2	NULL
14	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
9	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1.5	NULL
22.13	NULL
14.5	NULL
+	NULL
1.1	NULL
36.3	NULL
+	NULL
3.5	NULL
2.5	NULL
mM	NULL
Mg	NULL
Cl	NULL
,	NULL
)	NULL
,	NULL
1.25	NULL
U	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
,	NULL
and	NULL
25	NULL
pM	NULL
of	NULL
an	NULL
equimolar	NULL
22.28	NULL
10.5	NULL
+	NULL
2.5	NULL
95.6	NULL
+	NULL
6.5	NULL
9.1	NULL
mix	NULL
of	NULL
specific	NULL
Va	NULL
primers	NULL
reported	NULL
in	NULL
Table	NULL
I.	NULL
Amplification	NULL
was	NULL
per-	NULL
22.34*	NULL
14.6	NULL
+	NULL
2.4	NULL
211.0	NULL
+	NULL
4.2	NULL
144	NULL
formed	NULL
in	NULL
a	NULL
96-well	NULL
thermocycler	NULL
(	NULL
PTC-100	NULL
;	NULL
MJ	NULL
Research	NULL
,	NULL
Cambridge	NULL
,	NULL
22.19	NULL
12.5	NULL
+	NULL
2.5	NULL
354.2	NULL
+	NULL
6.9	NULL
28.3	NULL
MA	NULL
)	NULL
with	NULL
the	NULL
following	NULL
cycle	NULL
:	NULL
1	NULL
X	NULL
(	NULL
94°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
45°C	NULL
for	NULL
1.5	NULL
min	NULL
,	NULL
and	NULL
22.18	NULL
12.1	NULL
+	NULL
2.2	NULL
500.2	NULL
+	NULL
10.5	NULL
41.3	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
30	NULL
%	NULL
(	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
45°C	NULL
for	NULL
1.5	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
2.3	NULL
8.8	NULL
+	NULL
2.5	NULL
448.0	NULL
+	NULL
8.4	NULL
50.9	NULL
min	NULL
)	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
migrated	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

Bands	NULL
of	NULL
interest	NULL
2.8	NULL
16.6	NULL
+	NULL
1.9	NULL
>	NULL
1000	NULL
>	NULL
1000	NULL
were	NULL
cut	NULL
out	NULL
and	NULL
incubated	NULL
overnight	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
buffered	NULL
phenol	NULL
.	NULL

A	NULL
total	NULL
2.19	NULL
17.3	NULL
+	NULL
2.2	NULL
>	NULL
1000	NULL
>	NULL
1000	NULL
of	NULL
50	NULL
gl	NULL
of	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
was	NULL
added	NULL
to	NULL
each	NULL
13.26	NULL
15.9	NULL
+	NULL
1.5	NULL
>	NULL
1000	NULL
>	NULL
1000	NULL
13.16	NULL
36.0	NULL
+	NULL
1.5	NULL
>	NULL
3000	NULL
>	NULL
3000	NULL
tube	NULL
,	NULL
which	NULL
was	NULL
then	NULL
centrifuged	NULL
at	NULL
13,000	NULL
rpm	NULL
in	NULL
a	NULL
microcentrifuge	NULL
for	NULL
1	NULL
h.	NULL
Aqueous	NULL
phase	NULL
was	NULL
recovered	NULL
,	NULL
extracted	NULL
once	NULL
with	NULL
phenol	NULL
chloroform	NULL
(	NULL
1:1	NULL
)	NULL
,	NULL
and	NULL
ethanol	NULL
precipitated	NULL
.	NULL

DNA	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
10	NULL
pul	NULL
of	NULL
1X	NULL
Sequenase	NULL
Rxn	NULL
buffer	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
with	NULL
1	NULL
M	NULL
of	NULL
sequencing	NULL
primer	NULL
5'-CTTTGTGACACATTTGTTTGAG-3	NULL
'	NULL
.	NULL

*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
BLCL	NULL
,	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
;	NULL
CDR	NULL
,	NULL
comple-mentarity-determining	NULL
region	NULL
.	NULL

``	NULL
Cytotoxicity	NULL
response	NULL
curves	NULL
against	NULL
autologous	NULL
BLCL	NULL
loaded	NULL
with	NULL
variable	NULL
concentrations	NULL
of	NULL
the	NULL
BZLF1	NULL
peptide	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
saturating	NULL
amounts	NULL
of	NULL
blocking	NULL
anti-CD8	NULL
mAb	NULL
were	NULL
fitted	NULL
using	NULL
a	NULL
single	NULL
binding	NULL
site	NULL
model	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
,	NULL
and	NULL
EDs	NULL
,	NULL
were	NULL
calculated	NULL
.	NULL

The	NULL
ratio	NULL
between	NULL
EDs	NULL
,	NULL
with	NULL
anti-CD8	NULL
and	NULL
without	NULL
anti-CD8	NULL
mAb	NULL
reflects	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
coreceptor	NULL
CD8	NULL
in	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
target	NULL
cells	NULL
.	NULL

(	NULL
The	NULL
*	NULL
indicates	NULL
that	NULL
clone	NULL
22.34	NULL
displayed	NULL
a	NULL
peculiar	NULL
behaviour	NULL
in	NULL
that	NULL
blocking	NULL
of	NULL
CD8	NULL
interaction	NULL
significantly	NULL
affected	NULL
its	NULL
TCR	NULL
binding	NULL
as	NULL
discussed	NULL
in	NULL
the	NULL
text	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
1	NULL
min	NULL
,	NULL
50°C	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
5X	NULL
(	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
45°C	NULL
for	NULL
2.5	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
.	NULL

Since	NULL
this	NULL
first	NULL
PCR	NULL
resulted	NULL
in	NULL
numerous	NULL
nonspecific	NULL
bands	NULL
due	NULL
to	NULL
the	NULL
use	NULL
of	NULL
degenerated	NULL
primers	NULL
,	NULL
a	NULL
second	NULL
PCR	NULL
was	NULL
conducted	NULL
on	NULL
0.5	NULL
pl	NULL
of	NULL
the	NULL
first	NULL
PCR	NULL
completed	NULL
to	NULL
50	NULL
ul	NULL
with	NULL
1X	NULL
Mix	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
;	NULL
12.5	NULL
pM	NULL
of	NULL
each	NULL
degenerated	NULL
primer	NULL
,	NULL
VBA	NULL
and	NULL
VBB	NULL
;	NULL
and	NULL
25	NULL
pM	NULL
of	NULL
a	NULL
nested	NULL
specific	NULL
CB	NULL
primer	NULL
,	NULL
CBII	NULL
5-GTGGCCAGGCA	NULL
CACCAGTGTG-3	NULL
'	NULL
with	NULL
the	NULL
following	NULL
cycle	NULL
:	NULL
5X	NULL
(	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
60°C	NULL
for	NULL
4	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
35	NULL
%	NULL
(	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
45°C	NULL
for	NULL
2.5	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
.	NULL

Bands	NULL
of	NULL
interest	NULL
were	NULL
purified	NULL
and	NULL
sequenced	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
for	NULL
Va	NULL
sequences	NULL
.	NULL

Cytotoxicity	NULL
assays	NULL
Cytotoxicity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
standard	NULL
4-h	NULL
*	NULL
``	NULL
Cr	NULL
release	NULL
assay	NULL
.	NULL

Briefly	NULL
,	NULL
2	NULL
X	NULL
10°	NULL
autologous	NULL
BLCL	NULL
were	NULL
labeled	NULL
with	NULL
50	NULL
Ci	NULL
of	NULL
*'Cr	NULL
(	NULL
Na	NULL
,	NULL
``	NULL
CrO	NULL
,	NULL
;	NULL
Oris	NULL
Industries	NULL
,	NULL
Gif	NULL
sur	NULL
Yvette	NULL
,	NULL
France	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
washed	NULL
five	NULL
times	NULL
,	NULL
and	NULL
pulsed	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
peptide	NULL
for	NULL
1.5	NULL
h	NULL
in	NULL
RPMI	NULL
1640	NULL
10	NULL
%	NULL
human	NULL
serum	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
,	NULL
target	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
different	NULL
T	NULL
cell	NULL
clones	NULL
at	NULL
an	NULL
E	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
10:1	NULL
in	NULL
150	NULL
pl	NULL
of	NULL
RPMI	NULL
1640	NULL
10	NULL
%	NULL
human	NULL
serum	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Twenty-five	NULL
microliters	NULL
of	NULL
supernatants	NULL
were	NULL
then	NULL
removed	NULL
and	NULL
mixed	NULL
with	NULL
100	NULL
pl	NULL
of	NULL
scintillation	NULL
mixture	NULL
(	NULL
Optiphase	NULL
Supermix	NULL
,	NULL
Wallac	NULL
,	NULL
U.K.	NULL
)	NULL
for	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

For	NULL
CD8	NULL
blockage	NULL
experiments	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
anti-CD8a	NULL
«	NULL
mAb	NULL
B9.11	NULL
(	NULL
Coultronics	NULL
,	NULL
Margency	NULL
,	NULL
France	NULL
)	NULL
for	NULL
15	NULL
min	NULL
before	NULL
incubation	NULL
with	NULL
the	NULL
target	NULL
cells	NULL
.	NULL

EDs	NULL
,	NULL
were	NULL
estimated	NULL
by	NULL
fitting	NULL
the	NULL
cytotoxicity	NULL
response	NULL
curves	NULL
with	NULL
the	NULL
GraFit	NULL
software	NULL
(	NULL
Erithacus	NULL
Software	NULL
,	NULL
Staines	NULL
,	NULL
UK	NULL
)	NULL
using	NULL
a	NULL
single	NULL
binding	NULL
site	NULL
model	NULL
.	NULL

For	NULL
alanine	NULL
scan	NULL
analysis	NULL
,	NULL
the	NULL
different	NULL
clones	NULL
were	NULL
tested	NULL
for	NULL
cytotoxicity	NULL
against	NULL
autologous	NULL
BLCL	NULL
loaded	NULL
with	NULL
10	NULL
,	NULL
0.5	NULL
,	NULL
or	NULL
0.25	NULL
uM	NULL
of	NULL
each	NULL
peptide	NULL
variant	NULL
(	NULL
derived	NULL
from	NULL
the	NULL
wild-type	NULL
BZLF1	NULL
9-mer	NULL
peptide	NULL
by	NULL
alanine	NULL
substitution	NULL
at	NULL
each	NULL
position	NULL
)	NULL
at	NULL
an	NULL
E	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
30:1	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
percentage	NULL
of	NULL
the	NULL
cytotoxicity	NULL
obtained	NULL
with	NULL
the	NULL
wild-type	NULL
peptide	NULL
in	NULL
the	NULL
same	NULL
conditions	NULL
.	NULL

Cytokine	NULL
production	NULL
The	NULL
melanoma	NULL
cell	NULL
line	NULL
M88	NULL
expressing	NULL
HLA-B4002	NULL
was	NULL
used	NULL
as	NULL
APC	NULL
in	NULL
this	NULL
test	NULL
because	NULL
it	NULL
was	NULL
easier	NULL
to	NULL
exclude	NULL
M88	NULL
cells	NULL
by	NULL
size	NULL
from	NULL
T	NULL
cell	NULL
clones	NULL
in	NULL
the	NULL
following	NULL
flow-cytometric	NULL
analysis	NULL
.	NULL

M88	NULL
cells	NULL
were	NULL
pulsed	NULL
for	NULL
1.5	NULL
h	NULL
at	NULL
37°C	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
BZLF1	NULL
peptide	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
without	NULL
FCS	NULL
and	NULL
washed	NULL
twice	NULL
to	NULL
avoid	NULL
autopresentation	NULL
by	NULL
T	NULL
cells	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
by	NULL
4	NULL
X	NULL
10°	NULL
peptide-pulsed	NULL
M88	NULL
cells	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
without	NULL
IL-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
of	NULL
Brefeldin	NULL
A	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
for	NULL
6	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

For	NULL
intracytoplasmic	NULL
staining	NULL
,	NULL
cells	NULL
were	NULL
then	NULL
fixed	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
solution	NULL
of	NULL
PBS	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
large	NULL
volumes	NULL
of	NULL
PBS	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
4°C	NULL
until	NULL
immunofluorescence	NULL
analysis	NULL
.	NULL

Flow-cytometric	NULL
analysis	NULL
of	NULL
intracellular	NULL
cytokines	NULL
Fixed	NULL
stimulated	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
stained	NULL
for	NULL
cytokines	NULL
using	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Jung	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
fixed	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
the	NULL
different	NULL
mAbs	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
5	NULL
pg/ml	NULL
(	NULL
shown	NULL
to	NULL
provide	NULL
optimal	NULL
staining	NULL
for	NULL
mAbs	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Monoclonal	NULL
FITC-conjugated	NULL
anti-human	NULL
IFN-y	NULL
(	NULL
48.B3	NULL
)	NULL
and	NULL
PE-conjugated	NULL
anti-human	NULL
IL-2	NULL
(	NULL
MQ1-17H12	NULL
)	NULL
Ab	NULL
were	NULL
purchased	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Reagent	NULL
dilutions	NULL
and	NULL
washes	NULL
were	NULL
done	NULL
with	NULL
PBS	NULL
containing	NULL
0.1	NULL
%	NULL
BSA	NULL
(	NULL
A-9647	NULL
;	NULL
Sigma	NULL
,	NULL
Saint	NULL
Quentin	NULL
Fallavier	NULL
,	NULL
France	NULL
)	NULL
and	NULL
0.1	NULL
%	NULL
saponin	NULL
(	NULL
Sig-ma	NULL
)	NULL
.	NULL

After	NULL
staining	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
PBS	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
using	NULL
Cellquest	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Grenoble	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Results	NULL
Structural	NULL
features	NULL
of	NULL
«	NULL
and	NULL
BB	NULL
TCR	NULL
chains	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
selected	NULL
in	NULL
vivo	NULL
against	NULL
a	NULL
single	NULL
MHC/peptide	NULL
complex	NULL
To	NULL
evaluate	NULL
the	NULL
diversity	NULL
and	NULL
stability	NULL
of	NULL
TCR	NULL
repertoire	NULL
of	NULL
T	NULL
cells	NULL
involved	NULL
in	NULL
a	NULL
chronic	NULL
in	NULL
vivo	NULL
response	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
structural	NULL
analysis	NULL
of	NULL
TCR	NULL
chains	NULL
from	NULL
synovial	NULL
T	NULL
cell	NULL
clones	NULL
derived	NULL
from	NULL
a	NULL
patient	NULL
whose	NULL
response	NULL
was	NULL
predominantly	NULL
directed	NULL
against	NULL
a	NULL
single	NULL
viral	NULL
peptide/MHC	NULL
complex	NULL
(	NULL
BZLF1/HLA-B4002	NULL
)	NULL
.	NULL

Since	NULL
recently	NULL
published	NULL
x-ray	NULL
crystallographic	NULL
data	NULL
of	NULL
TCR/peptide/	NULL
MHC	NULL
demonstrate	NULL
an	NULL
implication	NULL
of	NULL
both	NULL
the	NULL
a-	NULL
and	NULL
the	NULL
-chain	NULL
of	NULL
the	NULL
TCR	NULL
in	NULL
peptide/MHC	NULL
(	NULL
14-17	NULL
)	NULL
,	NULL
it	NULL
is	NULL
crucial	NULL
to	NULL
sequence	NULL
both	NULL
TCR	NULL
chains	NULL
to	NULL
analyze	NULL
structural	NULL
constraints	NULL
imposed	NULL
by	NULL
recognition	NULL
of	NULL
a	NULL
given	NULL
HLA	NULL
peptide	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
clones	NULL
established	NULL
after	NULL
V	NULL
B-specific	NULL
irnimunosorting	NULL
,	NULL
characterization	NULL
of	NULL
CDR3B	NULL
was	NULL
conducted	NULL
by	NULL
sequencing	NULL
RT-PCR	NULL
products	NULL
using	NULL
specific	NULL
VB	NULL
primers	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
6353	NULL
clones	NULL
randomly	NULL
isolated	NULL
from	NULL
synovial	NULL
membrane	NULL
infiltrating	NULL
lym-phocytes	NULL
,	NULL
we	NULL
developed	NULL
an	NULL
RT-PCR	NULL
approach	NULL
using	NULL
degenerated	NULL
VB	NULL
primers	NULL
.	NULL

Va	NULL
transcript	NULL
amplification	NULL
was	NULL
performed	NULL
by	NULL
multiplex	NULL
PCR	NULL
because	NULL
absence	NULL
of	NULL
allelic	NULL
exclusion	NULL
in	NULL
the	NULL
a	NULL
locus	NULL
prohibits	NULL
the	NULL
use	NULL
of	NULL
degenerated	NULL
primers	NULL
.	NULL

Va	NULL
and	NULL
VB	NULL
sequences	NULL
of	NULL
the	NULL
different	NULL
clones	NULL
are	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

We	NULL
found	NULL
that	NULL
clones	NULL
from	NULL
the	NULL
second	NULL
sample	NULL
expressing	NULL
BV1S1	NULL
,	NULL
BV2S1	NULL
,	NULL
BV14S1	NULL
,	NULL
and	NULL
BV22S1	NULL
were	NULL
already	NULL
present	NULL
in	NULL
the	NULL
first	NULL
sample	NULL
collected	NULL
2	NULL
yr	NULL
earlier	NULL
.	NULL

The	NULL
remaining	NULL
clones	NULL
whose	NULL
VB	NULL
had	NULL
not	NULL
been	NULL
analyzed	NULL
in	NULL
the	NULL
first	NULL
sample	NULL
(	NULL
namely	NULL
BV6S4	NULL
and	NULL
BV18S1	NULL
)	NULL
corresponded	NULL
to	NULL
minor	NULL
subsets	NULL
for	NULL
which	NULL
specific	NULL
amplification	NULL
was	NULL
nevertheless	NULL
demonstrated	NULL
in	NULL
the	NULL
first	NULL
sample	NULL
by	NULL
immunoscope	NULL
analysis	NULL
in	NULL
a	NULL
previous	NULL
study	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Whether	NULL
this	NULL
repertoire	NULL
persistence	NULL
results	NULL
from	NULL
a	NULL
process	NULL
of	NULL
affinity	NULL
selection	NULL
will	NULL
be	NULL
discussed	NULL
below	NULL
in	NULL
light	NULL
of	NULL
the	NULL
functional	NULL
analysis	NULL
.	NULL

The	NULL
most	NULL
striking	NULL
feature	NULL
was	NULL
the	NULL
important	NULL
repertoire	NULL
diversity	NULL
of	NULL
reactive	NULL
clones	NULL
,	NULL
with	NULL
9	NULL
VB	NULL
,	NULL
7	NULL
JB	NULL
,	NULL
10	NULL
Va	NULL
,	NULL
and	NULL
11	NULL
Ja	NULL
represented	NULL
.	NULL

Because	NULL
of	NULL
this	NULL
diversity	NULL
,	NULL
it	NULL
was	NULL
relevant	NULL
to	NULL
look	NULL
for	NULL
a	NULL
selection	NULL
process	NULL
on	NULL
CDR3	NULL
only	NULL
among	NULL
clones	NULL
sharing	NULL
at	NULL
least	NULL
one	NULL
of	NULL
these	NULL
elements	NULL
.	NULL

Among	NULL
clones	NULL
using	NULL
V	NULL
B2	NULL
,	NULL
two	NULL
clones	NULL
,	NULL
namely	NULL
A2.3	NULL
and	NULL
A2.8	NULL
,	NULL
shared	NULL
the	NULL
same	NULL
Va	NULL
,	NULL
Ja	NULL
,	NULL
V	NULL
B	NULL
,	NULL
and	NULL
J	NULL
elements	NULL
.	NULL

For	NULL
these	NULL
two	NULL
clones	NULL
,	NULL
structural	NULL
constraints	NULL
were	NULL
also	NULL
apparent	NULL
on	NULL
CDR3	NULL
regions	NULL
,	NULL
with	NULL
equal	NULL
length	NULL
of	NULL
both	NULL
CDR3a	NULL
and	NULL
B	NULL
.	NULL

Moreover	NULL
,	NULL
these	NULL
two	NULL
clones	NULL
shared	NULL
conserved	NULL
N-encoded	NULL
residues	NULL
in	NULL
the	NULL
CDR3	NULL
(	NULL
3	NULL
region	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
TCR	NULL
structural	NULL
constraints	NULL
in	NULL
these	NULL
clones	NULL
resulted	NULL
from	NULL
a	NULL
stringent	NULL
selection	NULL
process	NULL
.	NULL

These	NULL
CDR3	NULL
sequence	NULL
homologies	NULL
disappeared	NULL
when	NULL
a	NULL
different	NULL
combination	NULL
of	NULL
Va/VB	NULL
was	NULL
considered	NULL
,	NULL
as	NULL
can	NULL
be	NULL
seen	NULL
with	NULL
clone	NULL
A2.19	NULL
(	NULL
VB2	NULL
)	NULL
,	NULL
which	NULL
used	NULL
different	NULL
Va	NULL
,	NULL
Ja	NULL
,	NULL
JB	NULL
than	NULL
clones	NULL
A2.3	NULL
and	NULL
A2.8	NULL
,	NULL
with	NULL
clones	NULL
A13.16	NULL
and	NULL
A13.26	NULL
,	NULL
which	NULL
shared	NULL
the	NULL
same	NULL
V	NULL
(	NULL
and	NULL
JB	NULL
,	NULL
but	NULL
used	NULL
different	NULL
«	NULL
-chains	NULL
,	NULL
or	NULL
among	NULL
the	NULL
five	NULL
V	NULL
B22	NULL
clones	NULL
.	NULL

A	NULL
similar	NULL
conclusion	NULL
could	NULL
be	NULL
drawn	NULL
when	NULL
considering	NULL
clones	NULL
using	NULL
the	NULL
same	NULL
Va	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
there	NULL
was	NULL
no	NULL
obvious	NULL
predominance	NULL
of	NULL
the	NULL
a-	NULL
or	NULL
the	NULL
-chain	NULL
in	NULL
selecting	NULL
reactive	NULL
clones	NULL
.	NULL

Nevertheless	NULL
,	NULL
although	NULL
there	NULL
was	NULL
no	NULL
preferential	NULL
association	NULL
between	NULL
any	NULL
particular	NULL
Va	NULL
and	NULL
Ja	NULL
,	NULL
a	NULL
recurrent	NULL
use	NULL
of	NULL
particular	NULL
Va	NULL
and	NULL
Ja	NULL
elements	NULL
was	NULL
observed	NULL
:	NULL
Va	NULL
28s1	NULL
(	NULL
three	NULL
clones	NULL
)	NULL
;	NULL
Va	NULL
25s1	NULL
,	NULL
22s1	NULL
,	NULL
and	NULL
101s1	NULL
(	NULL
two	NULL
clones	NULL
each	NULL
)	NULL
;	NULL
Ja	NULL
8	NULL
(	NULL
three	NULL
clones	NULL
)	NULL
;	NULL
Ja	NULL
28	NULL
and	NULL
50	NULL
(	NULL
two	NULL
clones	NULL
each	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
all	NULL
clones	NULL
except	NULL
one	NULL
used	NULL
at	NULL
least	NULL
one	NULL
recurrent	NULL
Va	NULL
or	NULL
one	NULL
recurrent	NULL
Ja	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
over-representation	NULL
of	NULL
JB	NULL
2s3	NULL
and	NULL
287	NULL
,	NULL
regardless	NULL
of	NULL
VB	NULL
usage	NULL
that	NULL
we	NULL
detected	NULL
by	NULL
immunoscope	NULL
among	NULL
B4002/BZLF1	NULL
reactive	NULL
clones	NULL
in	NULL
a	NULL
previous	NULL
study	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
great	NULL
diversity	NULL
observed	NULL
in	NULL
our	NULL
panel	NULL
of	NULL
clones	NULL
demonstrates	NULL
that	NULL
B4002/BZLF1	NULL
is	NULL
very	NULL
permissive	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
selects	NULL
a	NULL
large	NULL
set	NULL
of	NULL
V	NULL
and	NULL
J	NULL
elements	NULL
,	NULL
each	NULL
of	NULL
which	NULL
probably	NULL
engages	NULL
in	NULL
different	NULL
types	NULL
of	NULL
contacts	NULL
with	NULL
it	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
clones	NULL
expressing	NULL
VB2	NULL
and	NULL
V	NULL
B22	NULL
that	NULL
were	NULL
represented	NULL
by	NULL
three	NULL
and	NULL
five	NULL
clonotypes	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
of	NULL
peculiar	NULL
interest	NULL
in	NULL
that	NULL
they	NULL
could	NULL
be	NULL
considered	NULL
as	NULL
representative	NULL
of	NULL
stringent	NULL
or	NULL
moderate	NULL
TCR	NULL
structural	NULL
constraints	NULL
both	NULL
on	NULL
combinatorial	NULL
and	NULL
junctional	NULL
diversity	NULL
.	NULL

We	NULL
therefore	NULL
further	NULL
investigated	NULL
their	NULL
different	NULL
modes	NULL
of	NULL
contact	NULL
with	NULL
the	NULL
selecting	NULL
HLA/peptide	NULL
by	NULL
alanine	NULL
scan	NULL
analysis	NULL
.	NULL

Alanine	NULL
scan	NULL
analysis	NULL
The	NULL
results	NULL
of	NULL
the	NULL
alanine	NULL
scan	NULL
analysis	NULL
are	NULL
represented	NULL
on	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Alanine	NULL
substitution	NULL
in	NULL
positions	NULL
2	NULL
and	NULL
9	NULL
,	NULL
characterized	NULL
as	NULL
peptide	NULL
anchor	NULL
residues	NULL
by	NULL
computer	NULL
modelization	NULL
,	NULL
abrogated	NULL
response	NULL
in	NULL
the	NULL
former	NULL
case	NULL
,	NULL
but	NULL
had	NULL
little	NULL
effect	NULL
for	NULL
the	NULL
latter	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
alanine	NULL
at	NULL
position	NULL
9	NULL
is	NULL
frequently	NULL
used	NULL
as	NULL
an	NULL
anchor	NULL
residue	NULL
in	NULL
B4002	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
HLA	NULL
Peptide	NULL
Binding	NULL
Prediction	NULL
(	NULL
18	NULL
)	NULL
.	NULL

When	NULL
we	NULL
tested	NULL
the	NULL
whole	NULL
panel	NULL
of	NULL
clones	NULL
on	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6354	NULL
AVIDITY	NULL
,	NULL
NOT	NULL
TCR	NULL
AFFINITY	NULL
,	NULL
RULES	NULL
IN	NULL
VIVO	NULL
SELECTION	NULL
OF	NULL
EBV-REACTIVE	NULL
CTL	NULL
Clones	NULL
from	NULL
Clones	NULL
from	NULL
vB	NULL
consf	NULL
JB	NULL
va.	NULL
CDR3CO	NULL
,	NULL
Jao	NULL
Non	NULL
the	NULL
the	NULL
functional	NULL
a	NULL
1°	NULL
sample	NULL
2	NULL
``	NULL
sample	NULL
chain	NULL
vo	NULL
JG	NULL
6.1	NULL
654	NULL
CAS	NULL
SLEOGYRGSYNEQ	NULL
FFG	NULL
2s1	NULL
-	NULL
isl	NULL
CAV	NULL
NAEYSGAGSYQL	NULL
TFG	NULL
28	NULL
22.13	NULL
8.11	NULL
2281	NULL
Cas	NULL
SsHLGGGEQ	NULL
yFG	NULL
2s7	NULL
30s1	NULL
-	NULL
CAV	NULL
QVLYSGAGSYQL	NULL
TFG	NULL
28	NULL
13s1	NULL
37	NULL
22.28	NULL
2281	NULL
CAG	NULL
RTGERDEQ	NULL
FFG	NULL
2s1	NULL
101s1	NULL
CAL	NULL
CWAANAGKS	NULL
TFG	NULL
27	NULL
9s1	NULL
53	NULL
22.19	NULL
22s1	NULL
CAR	NULL
SGTYTGEL	NULL
FFG	NULL
2932	NULL
28s1	NULL
CAP	NULL
LIYNQGGKL	NULL
IFG	NULL
23	NULL
13s1	NULL
23	NULL
22.18	NULL
2281	NULL
CAS	NULL
SCEVFTKITDTQ	NULL
YFG	NULL
2s3	NULL
22s1	NULL
CAL	NULL
RSSGGSNYKL	NULL
TFG	NULL
53	NULL
4s2	NULL
49	NULL
22.34	NULL
2281	NULL
CAS	NULL
SspVPGOGENYGY	NULL
TFG	NULL
1s2	NULL
1s5	NULL
CVV	NULL
sSSMNTGFQKL	NULL
-	NULL
VFrG	NULL
8	NULL
2.3	NULL
281	NULL
CSA	NULL
REDPSYEQ	NULL
yFG	NULL
2s7	NULL
781	NULL
CAA	NULL
NTGFQKL	NULL
vFG	NULL
8	NULL
2.8	NULL
8.8	NULL
281	NULL
CSA	NULL
RADPSYEQ	NULL
YFG	NULL
2s7	NULL
7s1	NULL
CAG	NULL
GAGFQKL	NULL
vFG	NULL
8	NULL
5s1	NULL
8	NULL
2.19	NULL
281	NULL
CSA	NULL
SYLAGTTQ	NULL
vrG	NULL
2s3	NULL
23s1	NULL
-	NULL
CAG	NULL
GGSYGKL	NULL
TFG	NULL
52	NULL
8.20	NULL
18s1	NULL
CAS	NULL
SPPLGTYEQ	NULL
YFG	NULL
2s7	NULL
2581	NULL
-	NULL
CAG	NULL
QLVDKV	NULL
IFG	NULL
50	NULL
-	NULL
32s1	NULL
50	NULL
13.26	NULL
13s2	NULL
CAS	NULL
SNLDGLHPGA	NULL
FFG	NULL
1s1	NULL
25s1	NULL
-	NULL
CAV	NULL
SSTGCTASKL	NULL
TFG	NULL
44	NULL
8s2	NULL
37	NULL
13.16	NULL
1382	NULL
CAS	NULL
SYMSPNTEA	NULL
FFG	NULL
1s1	NULL
28s1	NULL
-	NULL
CAV	NULL
GRTSYDKV	NULL
Irc	NULL
50	NULL
5.1	NULL
5s1	NULL
CAS	NULL
SLYSPYEQ	NULL
YFG	NULL
2s7	NULL
28s1	NULL
CAV	NULL
GENQGGSEKL	NULL
-	NULL
vFrG	NULL
57	NULL
4s2	NULL
54	NULL
1.1	NULL
8.18	NULL
1s1	NULL
CAS	NULL
SvGLTco®To	NULL
yrG	NULL
2s5	NULL
101s1	NULL
CAL	NULL
GAVYOARL	NULL
MFG	NULL
31	NULL
20s1	NULL
40	NULL
14.7	NULL
8.25	NULL
14s1	NULL
CAS	NULL
SFNLGGLGDTQ	NULL
YFG	NULL
2s3	NULL
6s1	NULL
CAL	NULL
REIQGAQKL	NULL
vrG	NULL
54	NULL
2281	NULL
CAL	NULL
PRIQGAQKL	NULL
vrG	NULL
54	NULL
FIGURE	NULL
1	NULL
.	NULL

Amino	NULL
acid	NULL
sequences	NULL
of	NULL
TCR	NULL
a	NULL
and	NULL
B	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
junctional	NULL
regions	NULL
of	NULL
BZLF1-B4002-reactive	NULL
clones	NULL
.	NULL

Amino	NULL
acids	NULL
encoded	NULL
by	NULL
N	NULL
(	NULL
D	NULL
)	NULL
N	NULL
nucleotides	NULL
are	NULL
underlined	NULL
.	NULL

Clones	NULL
from	NULL
the	NULL
first	NULL
sample	NULL
were	NULL
obtained	NULL
after	NULL
immunosorting	NULL
with	NULL
mAb	NULL
specific	NULL
for	NULL
VB	NULL
that	NULL
were	NULL
overrepresented	NULL
in	NULL
the	NULL
joint	NULL
of	NULL
the	NULL
patient	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Clones	NULL
of	NULL
the	NULL
second	NULL
sample	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
CD8	NULL
*	NULL
cell	NULL
line	NULL
obtained	NULL
from	NULL
the	NULL
synovial	NULL
membrane	NULL
of	NULL
the	NULL
same	NULL
patient	NULL
27	NULL
mo	NULL
later	NULL
.	NULL

Functional	NULL
or	NULL
nonfunctional	NULL
a	NULL
rearrangements	NULL
detected	NULL
on	NULL
the	NULL
second	NULL
allele	NULL
are	NULL
indicated	NULL
.	NULL

TCR	NULL
Va	NULL
and	NULL
VB	NULL
nomenclature	NULL
are	NULL
from	NULL
Arden	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
,	NULL
Ja	NULL
nomenclature	NULL
are	NULL
from	NULL
Koop	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
JB	NULL
nomenclature	NULL
are	NULL
from	NULL
Rowen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
.	NULL

peptides	NULL
substituted	NULL
at	NULL
positions	NULL
1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
,	NULL
we	NULL
always	NULL
been	NULL
frequently	NULL
described	NULL
as	NULL
a	NULL
crucial	NULL
contact	NULL
residue	NULL
for	NULL
both	NULL
observed	NULL
at	NULL
least	NULL
one	NULL
responsive	NULL
clone	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
vari-	NULL
CDR3a	NULL
and	NULL
$	NULL
,	NULL
abrogated	NULL
the	NULL
reactivity	NULL
of	NULL
all	NULL
clones	NULL
.	NULL

ants	NULL
could	NULL
still	NULL
bind	NULL
to	NULL
B4002	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
Reactivities	NULL
of	NULL
clones	NULL
A2.3	NULL
and	NULL
A2.8	NULL
were	NULL
abrogated	NULL
by	NULL
substitu-contrast	NULL
,	NULL
substitution	NULL
at	NULL
position	NULL
5	NULL
,	NULL
the	NULL
central	NULL
amino	NULL
acid	NULL
that	NULL
has	NULL
tion	NULL
at	NULL
positions	NULL
6	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
,	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
contacted	NULL
FIGURE	NULL
2	NULL
.	NULL

Fine	NULL
specificity	NULL
of	NULL
VB2-	NULL
and	NULL
VB22-ex-pressing	NULL
T	NULL
cell	NULL
clones	NULL
specific	NULL
for	NULL
the	NULL
BZLF1	NULL
peptide	NULL
SENDRLRLL	NULL
was	NULL
defined	NULL
by	NULL
alanine	NULL
scan	NULL
mutagen-esis	NULL
.	NULL

Sequence	NULL
of	NULL
the	NULL
wild-type	NULL
peptide	NULL
is	NULL
indicated	NULL
on	NULL
E	NULL
the	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
above	NULL
boxes	NULL
,	NULL
where	NULL
are	NULL
presented	NULL
the	NULL
results	NULL
obtained	NULL
for	NULL
each	NULL
Ala	NULL
substitution	NULL
.	NULL

Putative	NULL
22.19	NULL
anchor	NULL
residue	NULL
for	NULL
B4002	NULL
at	NULL
positions	NULL
2	NULL
and	NULL
9	NULL
of	NULL
the	NULL
peptide	NULL
has	NULL
been	NULL
determined	NULL
using	NULL
HLA	NULL
peptide-bind-	NULL
ing	NULL
prediction	NULL
(	NULL
BIMAS	NULL
)	NULL
software	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Clones	NULL
were	NULL
22.28	NULL
tested	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
kill	NULL
the	NULL
autologous	NULL
BLCL	NULL
loaded	NULL
with	NULL
10	NULL
,	NULL
0.5	NULL
,	NULL
and	NULL
0.025	NULL
mM	NULL
of	NULL
each	NULL
peptide	NULL
analogue	NULL
at	NULL
an	NULL
E	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
30:1	NULL
according	NULL
to	NULL
the	NULL
pro	NULL
tocol	NULL
described	NULL
for	NULL
cytotoxic	NULL
assay	NULL
.	NULL

Results	NULL
are	NULL
ex-	NULL
2.3	NULL
pressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
lysis	NULL
obtained	NULL
in	NULL
the	NULL
same	NULL
conditions	NULL
with	NULL
the	NULL
native	NULL
peptide	NULL
.	NULL

%	NULL
cytotoxicity	NULL
relative	NULL
to	NULL
wt	NULL
peptide	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
100	NULL
-O-	NULL
2218	NULL
-O-	NULL
2219	NULL
so	NULL
-	NULL
-Y-	NULL
22.28	NULL
A	NULL
-A-	NULL
2234	NULL
2	NULL
5	NULL
-	NULL
®-	NULL
-C-	NULL
22.13	NULL
®	NULL
9	NULL
-K-	NULL
4316	NULL
&	NULL
0	NULL
an-	NULL
$	NULL
--	NULL
13.26	NULL
i	NULL
5	NULL
a	NULL
.	NULL

-B-	NULL
2.3	NULL
20	NULL
-	NULL
--	NULL
&	NULL
--	NULL
_	NULL
2.8	NULL
-	NULL
#	NULL
-	NULL
2.19	NULL
0	NULL
T	NULL
T	NULL
T	NULL
P	NULL
6.1	NULL
1E-03	NULL
1E-02	NULL
12-01	NULL
1E+00	NULL
1E+01	NULL
Peptide	NULL
concentration	NULL
(	NULL
uM	NULL
)	NULL
FIGURE	NULL
3	NULL
.	NULL

Cytotoxic	NULL
response	NULL
of	NULL
11	NULL
BZLFl-reactive	NULL
CD8*	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Cytotoxicity	NULL
was	NULL
assessed	NULL
against	NULL
autologous	NULL
BLCL	NULL
pulsed	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
BZLF1	NULL
peptide	NULL
SENDRLRLL	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
mean	NULL
lysis	NULL
from	NULL
at	NULL
least	NULL
three	NULL
different	NULL
experiments	NULL
performed	NULL
at	NULL
an	NULL
E	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
10:1	NULL
.	NULL

SDs	NULL
were	NULL
within	NULL
15	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

by	NULL
the	NULL
B-chain	NULL
.	NULL

This	NULL
similar	NULL
profile	NULL
was	NULL
expected	NULL
since	NULL
those	NULL
clones	NULL
only	NULL
differed	NULL
by	NULL
1	NULL
aa	NULL
on	NULL
their	NULL
B-chain	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
these	NULL
two	NULL
clones	NULL
displayed	NULL
marked	NULL
differences	NULL
in	NULL
their	NULL
sensitivity	NULL
to	NULL
substitution	NULL
at	NULL
positions	NULL
3	NULL
and	NULL
4	NULL
,	NULL
while	NULL
they	NULL
only	NULL
differed	NULL
by	NULL
3	NULL
aa	NULL
on	NULL
their	NULL
«	NULL
-chain	NULL
in	NULL
the	NULL
CDR3	NULL
region	NULL
,	NULL
thus	NULL
suggesting	NULL
the	NULL
strong	NULL
involvement	NULL
of	NULL
their	NULL
CDR3	NULL
«	NULL
in	NULL
contacting	NULL
the	NULL
HLA/peptide	NULL
complex	NULL
.	NULL

Not	NULL
surprisingly	NULL
,	NULL
clone	NULL
A2.19	NULL
,	NULL
which	NULL
used	NULL
a	NULL
different	NULL
showed	NULL
a	NULL
distinct	NULL
pattern	NULL
of	NULL
sensivity	NULL
to	NULL
substitution	NULL
at	NULL
these	NULL
positions	NULL
.	NULL

However	NULL
,	NULL
this	NULL
clone	NULL
,	NULL
which	NULL
shared	NULL
VB2	NULL
with	NULL
A2.3	NULL
and	NULL
A2.8	NULL
,	NULL
but	NULL
markedly	NULL
differed	NULL
in	NULL
its	NULL
CDR3	NULL
$	NULL
region	NULL
,	NULL
was	NULL
almost	NULL
insensitive	NULL
to	NULL
substitution	NULL
at	NULL
position	NULL
7	NULL
,	NULL
thus	NULL
reinforcing	NULL
the	NULL
critical	NULL
contribution	NULL
of	NULL
CDR3	NULL
regions	NULL
of	NULL
V	NULL
B2	NULL
clones	NULL
in	NULL
establishing	NULL
contact	NULL
with	NULL
the	NULL
HLA/peptide	NULL
complex	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
,	NULL
V	NULL
B22	NULL
clones	NULL
displayed	NULL
a	NULL
very	NULL
similar	NULL
pattern	NULL
of	NULL
reactivities	NULL
despite	NULL
great	NULL
combinatorial	NULL
and	NULL
junctional	NULL
diversity	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
it	NULL
is	NULL
noteworthy	NULL
that	NULL
they	NULL
were	NULL
all	NULL
very	NULL
sensitive	NULL
to	NULL
alanine	NULL
substitution	NULL
at	NULL
positions	NULL
7	NULL
and	NULL
8	NULL
,	NULL
but	NULL
rather	NULL
insensitive	NULL
to	NULL
substitution	NULL
at	NULL
position	NULL
6	NULL
.	NULL

This	NULL
would	NULL
indicate	NULL
that	NULL
contribution	NULL
of	NULL
was	NULL
less	NULL
critical	NULL
in	NULL
clones	NULL
V	NULL
B22	NULL
than	NULL
in	NULL
clones	NULL
V	NULL
B2	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
a	NULL
stronger	NULL
engagement	NULL
of	NULL
CDR1B	NULL
and	NULL
CDR2¢	NULL
in	NULL
the	NULL
interaction	NULL
with	NULL
HLA/peptide	NULL
.	NULL

This	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
crystallographic	NULL
data	NULL
of	NULL
TCR/MCH/pep-tide	NULL
complex	NULL
,	NULL
demonstrating	NULL
variable	NULL
involvement	NULL
of	NULL
CDR1f	NULL
and	NULL
CDR2	NULL
$	NULL
in	NULL
the	NULL
contact	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
BZLFI-reactive	NULL
T	NULL
cell	NULL
clones	NULL
The	NULL
aim	NULL
of	NULL
this	NULL
analysis	NULL
was	NULL
to	NULL
determine	NULL
whether	NULL
we	NULL
could	NULL
detect	NULL
functional	NULL
differences	NULL
between	NULL
the	NULL
different	NULL
VB	NULL
families	NULL
of	NULL
clones	NULL
,	NULL
and	NULL
more	NULL
specifically	NULL
between	NULL
VB2	NULL
and	NULL
VB22	NULL
,	NULL
which	NULL
could	NULL
be	NULL
related	NULL
to	NULL
their	NULL
different	NULL
level	NULL
of	NULL
structural	NULL
constraints	NULL
.	NULL

Cytotoxic	NULL
activity	NULL
of	NULL
11	NULL
synovial	NULL
T	NULL
cell	NULL
clones	NULL
was	NULL
evaluated	NULL
against	NULL
autologous	NULL
BLCL	NULL
loaded	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
relevant	NULL
9-mer	NULL
BZLF1	NULL
peptide	NULL
.	NULL

As	NULL
shown	NULL
on	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
all	NULL
clones	NULL
displayed	NULL
a	NULL
very	NULL
similar	NULL
curve	NULL
of	NULL
cytotoxicity	NULL
,	NULL
except	NULL
for	NULL
clone	NULL
6.1	NULL
,	NULL
which	NULL
reproducedly	NULL
showed	NULL
a	NULL
lower	NULL
reactiv-ity	NULL
.	NULL

EDs	NULL
,	NULL
were	NULL
estimated	NULL
for	NULL
each	NULL
clone	NULL
from	NULL
at	NULL
least	NULL
three	NULL
distinct	NULL
experiments	NULL
and	NULL
are	NULL
reported	NULL
in	NULL
Table	NULL
I.	NULL
EDs	NULL
,	NULL
ranged	NULL
from	NULL
9-36	NULL
nM	NULL
,	NULL
showing	NULL
that	NULL
all	NULL
of	NULL
these	NULL
clones	NULL
were	NULL
very	NULL
similar	NULL
in	NULL
terms	NULL
of	NULL
peptide/MHC	NULL
requirements	NULL
for	NULL
cytotoxicity	NULL
,	NULL
regardless	NULL
of	NULL
their	NULL
TCR	NULL
diversity	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
report	NULL
(	NULL
19	NULL
)	NULL
,	NULL
Schodin	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
strong	NULL
correlations	NULL
between	NULL
the	NULL
number	NULL
of	NULL
MHC/peptide	NULL
on	NULL
the	NULL
target	NULL
cell	NULL
required	NULL
for	NULL
cytolysis	NULL
,	NULL
the	NULL
number	NULL
of	NULL
interacting	NULL
TCR	NULL
6355	NULL
complexes	NULL
,	NULL
and	NULL
the	NULL
affinity	NULL
of	NULL
the	NULL
TCR	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
avidity	NULL
of	NULL
the	NULL
TCR	NULL
complex	NULL
(	NULL
understood	NULL
as	NULL
the	NULL
sum	NULL
of	NULL
TCR	NULL
and	NULL
coreceptor	NULL
interactions	NULL
with	NULL
MHC/peptide	NULL
)	NULL
can	NULL
be	NULL
estimated	NULL
by	NULL
the	NULL
density	NULL
of	NULL
MHC/peptide	NULL
required	NULL
for	NULL
cytolysis	NULL
.	NULL

Our	NULL
data	NULL
thus	NULL
suggested	NULL
that	NULL
in	NULL
vivo	NULL
selection	NULL
and	NULL
long-term	NULL
persistence	NULL
determined	NULL
this	NULL
narrow	NULL
range	NULL
of	NULL
EDs	NULL
,	NULL
,	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
of	NULL
avidity	NULL
of	NULL
the	NULL
TCR/coreceptor	NULL
complex	NULL
.	NULL

The	NULL
next	NULL
step	NULL
was	NULL
to	NULL
investigate	NULL
whether	NULL
this	NULL
selection	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
avidity	NULL
correlated	NULL
with	NULL
a	NULL
stringent	NULL
selection	NULL
on	NULL
TCR	NULL
affinity	NULL
.	NULL

Numerous	NULL
studies	NULL
have	NULL
demonstrated	NULL
the	NULL
stabilizing	NULL
role	NULL
of	NULL
the	NULL
CDS	NULL
coreceptor	NULL
in	NULL
TCR/MHC/peptide	NULL
engagement	NULL
(	NULL
20-23	NULL
)	NULL
,	NULL
and	NULL
evaluation	NULL
of	NULL
CD8	NULL
dependency	NULL
in	NULL
Ag	NULL
recognition	NULL
has	NULL
been	NULL
used	NULL
to	NULL
indirectly	NULL
estimate	NULL
TCR	NULL
affinity	NULL
(	NULL
24	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
CD8	NULL
coreceptor	NULL
in	NULL
the	NULL
recognition	NULL
of	NULL
peptide-loaded	NULL
BLCL	NULL
by	NULL
our	NULL
different	NULL
clones	NULL
to	NULL
compare	NULL
their	NULL
TCR	NULL
affinity	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
performed	NULL
cytotoxicity	NULL
experiments	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
saturating	NULL
amounts	NULL
of	NULL
anti-CD8	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

For	NULL
all	NULL
but	NULL
one	NULL
clone	NULL
,	NULL
blocking	NULL
the	NULL
CD8	NULL
coreceptor	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
shift	NULL
of	NULL
the	NULL
cytotoxicity	NULL
response	NULL
curve	NULL
,	NULL
thus	NULL
demonstrating	NULL
a	NULL
contribution	NULL
of	NULL
CD8-MHC	NULL
interaction	NULL
in	NULL
the	NULL
stabilization	NULL
of	NULL
the	NULL
TCR	NULL
recognition	NULL
complex	NULL
.	NULL

As	NULL
shown	NULL
on	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
level	NULL
of	NULL
CD8	NULL
dependency	NULL
was	NULL
very	NULL
variable	NULL
from	NULL
one	NULL
clone	NULL
to	NULL
another	NULL
.	NULL

Nevertheless	NULL
,	NULL
when	NULL
the	NULL
ratio	NULL
between	NULL
EDs	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CD8	NULL
mAb	NULL
was	NULL
calculated	NULL
and	NULL
clones	NULL
ranked	NULL
accordingly	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
we	NULL
noted	NULL
that	NULL
CD8	NULL
dependency	NULL
correlated	NULL
with	NULL
VB	NULL
usage	NULL
:	NULL
most	NULL
V	NULL
B22	NULL
clones	NULL
were	NULL
weakly	NULL
CD8	NULL
dependent	NULL
,	NULL
whereas	NULL
VB2	NULL
and	NULL
VB13	NULL
were	NULL
strongly	NULL
CD8	NULL
dependent	NULL
.	NULL

No	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
level	NULL
of	NULL
CD3	NULL
or	NULL
CD8	NULL
expression	NULL
could	NULL
be	NULL
detected	NULL
by	NULL
FACS	NULL
analysis	NULL
that	NULL
might	NULL
have	NULL
accounted	NULL
for	NULL
these	NULL
differences	NULL
in	NULL
CD8	NULL
dependency	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
variations	NULL
most	NULL
likely	NULL
reflected	NULL
differences	NULL
in	NULL
TCR	NULL
affinity	NULL
,	NULL
with	NULL
TCR	NULL
using	NULL
V	NULL
B2	NULL
and	NULL
VB13	NULL
being	NULL
of	NULL
lower	NULL
affinity	NULL
for	NULL
the	NULL
HLA-B4002/BZLF1	NULL
complex	NULL
than	NULL
TCRVB6	NULL
and	NULL
most	NULL
TCRV	NULL
B22	NULL
.	NULL

Interestingly	NULL
,	NULL
clones	NULL
A2.3	NULL
and	NULL
A2.8	NULL
,	NULL
which	NULL
only	NULL
differed	NULL
by	NULL
3	NULL
aa	NULL
in	NULL
their	NULL
CDR3	NULL
«	NULL
and	NULL
1	NULL
aa	NULL
in	NULL
their	NULL
CDR3	NULL
$	NULL
,	NULL
showed	NULL
marked	NULL
differences	NULL
in	NULL
their	NULL
CD8	NULL
dependency	NULL
,	NULL
thus	NULL
reinforcing	NULL
the	NULL
critical	NULL
contribution	NULL
of	NULL
CDR3s	NULL
in	NULL
TCR	NULL
affinity	NULL
among	NULL
V	NULL
B2	NULL
clones	NULL
,	NULL
whereas	NULL
clones	NULL
VB22	NULL
showed	NULL
rather	NULL
homogenous	NULL
CDS	NULL
dependency	NULL
despite	NULL
marked	NULL
differences	NULL
in	NULL
their	NULL
CDR3	NULL
sequences	NULL
.	NULL

In	NULL
most	NULL
cases	NULL
,	NULL
a	NULL
significant	NULL
cytotoxic	NULL
response	NULL
could	NULL
be	NULL
restored	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD8	NULL
mAb	NULL
by	NULL
increasing	NULL
peptide-loading	NULL
concentrations	NULL
,	NULL
and	NULL
the	NULL
response	NULL
curves	NULL
obtained	NULL
paralleled	NULL
those	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD8	NULL
blockage	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
show	NULL
that	NULL
in	NULL
most	NULL
in-stances	NULL
,	NULL
increasing	NULL
the	NULL
density	NULL
of	NULL
peptide/MHC	NULL
complexes	NULL
at	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
target	NULL
cell	NULL
can	NULL
compensate	NULL
for	NULL
the	NULL
loss	NULL
of	NULL
global	NULL
avidity	NULL
due	NULL
to	NULL
CD8	NULL
blockage	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
previously	NULL
published	NULL
data	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
clone	NULL
22.34	NULL
displayed	NULL
a	NULL
peculiar	NULL
pattern	NULL
of	NULL
reactivity	NULL
:	NULL
its	NULL
behavior	NULL
was	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
the	NULL
other	NULL
VB22	NULL
T	NULL
cell	NULL
clones	NULL
in	NULL
that	NULL
its	NULL
cytotoxic	NULL
response	NULL
curve	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD8	NULL
mAb	NULL
consistently	NULL
plateaued	NULL
at	NULL
a	NULL
much	NULL
lower	NULL
value	NULL
than	NULL
the	NULL
maximum	NULL
obtained	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD8	NULL
blockage	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
in	NULL
the	NULL
case	NULL
of	NULL
clone	NULL
22.34	NULL
,	NULL
preventing	NULL
CDS-MHC	NULL
interaction	NULL
significantly	NULL
affected	NULL
the	NULL
affinity	NULL
of	NULL
its	NULL
TCR	NULL
for	NULL
the	NULL
MHC/peptide	NULL
complex	NULL
,	NULL
whereas	NULL
for	NULL
all	NULL
of	NULL
the	NULL
other	NULL
V	NULL
B22	NULL
clones	NULL
,	NULL
blockage	NULL
of	NULL
CD8	NULL
left	NULL
their	NULL
TCR	NULL
affinity	NULL
intact	NULL
.	NULL

We	NULL
then	NULL
asked	NULL
whether	NULL
clone	NULL
6.1	NULL
,	NULL
whose	NULL
cytotoxic	NULL
response	NULL
was	NULL
almost	NULL
unaffected	NULL
by	NULL
CD8	NULL
blockage	NULL
,	NULL
was	NULL
intrinsically	NULL
CD8	NULL
independent	NULL
or	NULL
whether	NULL
its	NULL
CD8	NULL
dependency	NULL
could	NULL
vary	NULL
with	NULL
the	NULL
affinity	NULL
of	NULL
its	NULL
TCR	NULL
for	NULL
the	NULL
peptide	NULL
presented	NULL
.	NULL

We	NULL
therefore	NULL
tested	NULL
the	NULL
cytotoxicity	NULL
of	NULL
clone	NULL
6.1	NULL
against	NULL
BLCL	NULL
loaded	NULL
with	NULL
the	NULL
variant	NULL
peptide	NULL
A7	NULL
(	NULL
alanine	NULL
substitution	NULL
at	NULL
position	NULL
7	NULL
of	NULL
the	NULL
BZLF1	NULL
9-mer	NULL
peptide	NULL
)	NULL
previously	NULL
shown	NULL
to	NULL
behave	NULL
as	NULL
a	NULL
weak	NULL
agonist	NULL
for	NULL
this	NULL
clone	NULL
.	NULL

As	NULL
shown	NULL
on	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
response	NULL
curve	NULL
against	NULL
A7	NULL
was	NULL
shifted	NULL
to	NULL
the	NULL
right	NULL
compared	NULL
with	NULL
that	NULL
against	NULL
the	NULL
BZLF1	NULL
peptide	NULL
,	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6356	NULL
100	NULL
BV22S1	NULL
it	NULL
22.18	NULL
80	NULL
-	NULL
--	NULL
@	NULL
--	NULL
_	NULL
2219	NULL
--	NULL
&	NULL
&	NULL
--	NULL
-	NULL
22.28	NULL
60	NULL
--	NULL
-	NULL
@	NULL
--	NULL
_	NULL
22.13	NULL
40	NULL
-|	NULL
--	NULL
¥	NULL
--	NULL
_	NULL
22.34	NULL
20	NULL
&	NULL
W	NULL
33	NULL
>	NULL
-	NULL
0	NULL
6	NULL
o	NULL
&	NULL
$	NULL
100	NULL
5	NULL
BV6S4	NULL
--	NULL
BR	NULL
--	NULL
6.1	NULL
0	NULL
§	NULL
-	NULL
$	NULL
07	NULL
q	NULL
.	NULL

60	NULL
40	NULL
20	NULL
0	NULL
T	NULL
T	NULL
T	NULL
1E-03	NULL
_	NULL
1E-02	NULL
-	NULL
1E-01	NULL
_	NULL
1E+00	NULL
-	NULL
1E+01	NULL
AVIDITY	NULL
,	NULL
NOT	NULL
TCR	NULL
AFFINITY	NULL
,	NULL
RULES	NULL
IN	NULL
VIVO	NULL
SELECTION	NULL
OF	NULL
EBV-REACTIVE	NULL
CTL	NULL
100	NULL
BV2S1	NULL
-H-	NULL
23	NULL
80	NULL
-	NULL
]	NULL
--	NULL
-	NULL
2.8	NULL
--	NULL
@	NULL
--	NULL
2.19	NULL
60	NULL
40	NULL
20	NULL
-	NULL
]	NULL
BV13S2	NULL
13.16	NULL
80	NULL
-	NULL
--	NULL
@	NULL
--	NULL
13.26	NULL
60	NULL
40	NULL
20	NULL
7	NULL
0	NULL
1E-03	NULL
1E-02	NULL
1E-01	NULL
1E+00	NULL
_	NULL
1E+01	NULL
Peptide	NULL
concentration	NULL
(	NULL
uM	NULL
)	NULL
FIGURE	NULL
4	NULL
.	NULL

TCR	NULL
affinities	NULL
evaluated	NULL
by	NULL
sensitivity	NULL
to	NULL
blocking	NULL
by	NULL
an	NULL
anti-CD8	NULL
mAb	NULL
.	NULL

Cytotoxicity	NULL
of	NULL
the	NULL
different	NULL
CD8	NULL
T	NULL
cell	NULL
clones	NULL
against	NULL
autologous	NULL
BLCL	NULL
loaded	NULL
with	NULL
the	NULL
BZLF1	NULL
peptide	NULL
was	NULL
assessed	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
open	NULL
symbols	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
filled	NULL
symbols	NULL
)	NULL
of	NULL
saturating	NULL
amounts	NULL
of	NULL
anti-CD8	NULL
«	NULL
mAb	NULL
.	NULL

CD3	NULL
and	NULL
CD8	NULL
expression	NULL
was	NULL
tested	NULL
in	NULL
parallel	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
and	NULL
showed	NULL
no	NULL
significant	NULL
variation	NULL
between	NULL
clones	NULL
.	NULL

as	NULL
expected	NULL
for	NULL
a	NULL
weak	NULL
agonist	NULL
.	NULL

But	NULL
the	NULL
most	NULL
striking	NULL
feature	NULL
was	NULL
that	NULL
the	NULL
response	NULL
against	NULL
A7	NULL
was	NULL
totally	NULL
abrogated	NULL
by	NULL
addition	NULL
of	NULL
an	NULL
anti-CD8	NULL
mAb	NULL
.	NULL

Thus	NULL
,	NULL
CD8	NULL
interaction	NULL
,	NULL
which	NULL
was	NULL
dispensable	NULL
for	NULL
the	NULL
recognition	NULL
of	NULL
the	NULL
full	NULL
agonist	NULL
BZLF1	NULL
peptide	NULL
by	NULL
clone	NULL
6.1	NULL
,	NULL
became	NULL
absolutely	NULL
required	NULL
when	NULL
a	NULL
weaker	NULL
agonist	NULL
was	NULL
presented	NULL
to	NULL
this	NULL
clone	NULL
.	NULL

This	NULL
clone	NULL
can	NULL
thus	NULL
modulate	NULL
its	NULL
CD8	NULL
dependency	NULL
depending	NULL
on	NULL
the	NULL
affinity	NULL
of	NULL
its	NULL
TCR	NULL
for	NULL
the	NULL
peptide/MHC	NULL
complex	NULL
presented	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
from	NULL
Viola	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
showing	NULL
that	NULL
sensitivity	NULL
to	NULL
inhibition	NULL
by	NULL
2	NULL
o	NULL
>	NULL
jon	NULL
--	NULL
-	NULL
BZLF1+	NULL
0	NULL
anti-CD8	NULL
9	NULL
g	NULL
-O-	NULL
AZ	NULL
C	NULL
©	NULL
8	NULL
-	NULL
#	NULL
-	NULL
AZ+	NULL
g	NULL
anti	NULL
-CD8	NULL
1E-02	NULL
1E-01	NULL
1E+00	NULL
1E+01	NULL
Peptide	NULL
concentration	NULL
(	NULL
M	NULL
)	NULL
FIGURE	NULL
5	NULL
.	NULL

Sensitivity	NULL
to	NULL
blocking	NULL
by	NULL
an	NULL
anti-CD8	NULL
mAb	NULL
depends	NULL
on	NULL
the	NULL
peptide	NULL
presented	NULL
.	NULL

The	NULL
cytotoxic	NULL
response	NULL
of	NULL
clone	NULL
6.1	NULL
was	NULL
evaluated	NULL
against	NULL
autologous	NULL
BLCL	NULL
loaded	NULL
with	NULL
either	NULL
the	NULL
native	NULL
BZLFI1	NULL
peptide	NULL
or	NULL
the	NULL
A7	NULL
variant	NULL
(	NULL
alanine	NULL
substitution	NULL
at	NULL
position	NULL
7	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
open	NULL
symbols	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
filled	NULL
symbols	NULL
)	NULL
of	NULL
saturating	NULL
amounts	NULL
of	NULL
anti-CD8a	NULL
«	NULL
mAb	NULL
.	NULL

anti-coreceptor	NULL
Abs	NULL
was	NULL
inversely	NULL
correlated	NULL
to	NULL
the	NULL
efficiency	NULL
of	NULL
TCR-ligand	NULL
interaction	NULL
.	NULL

Finally	NULL
,	NULL
to	NULL
look	NULL
for	NULL
possible	NULL
differences	NULL
in	NULL
quality	NULL
of	NULL
TCR	NULL
engagement	NULL
between	NULL
the	NULL
different	NULL
clones	NULL
,	NULL
we	NULL
analyzed	NULL
their	NULL
cytokine	NULL
response	NULL
.	NULL

All	NULL
of	NULL
those	NULL
clones	NULL
have	NULL
been	NULL
characterized	NULL
previously	NULL
as	NULL
being	NULL
of	NULL
the	NULL
Tel	NULL
phenotype	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
producing	NULL
IFN-y	NULL
and	NULL
IL-2	NULL
following	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
on	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
all	NULL
of	NULL
the	NULL
clones	NULL
tested	NULL
were	NULL
capable	NULL
of	NULL
producing	NULL
IFN-y	NULL
and	NULL
IL-2	NULL
in	NULL
response	NULL
to	NULL
BZLF1	NULL
,	NULL
and	NULL
although	NULL
there	NULL
was	NULL
some	NULL
variability	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
cytokine-producing	NULL
cells	NULL
among	NULL
the	NULL
different	NULL
clones	NULL
,	NULL
these	NULL
variations	NULL
could	NULL
not	NULL
be	NULL
correlated	NULL
with	NULL
VB	NULL
usage	NULL
.	NULL

When	NULL
intensity	NULL
of	NULL
fluorescence	NULL
was	NULL
plotted	NULL
instead	NULL
of	NULL
percentage	NULL
of	NULL
positive	NULL
cells	NULL
,	NULL
identical	NULL
results	NULL
were	NULL
obtained	NULL
demonstrating	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
cytokine	NULL
produced	NULL
was	NULL
strictly	NULL
correlated	NULL
with	NULL
the	NULL
number	NULL
of	NULL
responding	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
efficiency	NULL
of	NULL
cytokine	NULL
production	NULL
triggering	NULL
through	NULL
the	NULL
TCR	NULL
could	NULL
not	NULL
distinguish	NULL
between	NULL
the	NULL
different	NULL
VB	NULL
families	NULL
.	NULL

Discussion	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
first	NULL
analyzed	NULL
TCR	NULL
a-	NULL
and	NULL
B-chain	NULL
sequences	NULL
of	NULL
B4002/BZLF1l-reactive	NULL
clones	NULL
that	NULL
were	NULL
specifically	NULL
amplified	NULL
in	NULL
the	NULL
joint	NULL
of	NULL
a	NULL
rheumatoid	NULL
arthritis	NULL
patient	NULL
.	NULL

The	NULL
repertoire	NULL
was	NULL
very	NULL
diverse	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
recognition	NULL
of	NULL
a	NULL
dominant	NULL
epitope	NULL
,	NULL
as	NULL
demonstrated	NULL
in	NULL
previous	NULL
reports	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
27	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
EBV	NULL
early	NULL
lytic	NULL
cycle	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
frequent	NULL
targets	NULL
of	NULL
CTL	NULL
in	NULL
primary	NULL
and	NULL
memory	NULL
responses	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

No	NULL
obvious	NULL
shared	NULL
structural	NULL
features	NULL
could	NULL
be	NULL
evidenced	NULL
among	NULL
clones	NULL
sharing	NULL
the	NULL
same	NULL
VB	NULL
,	NULL
except	NULL
for	NULL
some	NULL
V	NULL
B2	NULL
clones	NULL
,	NULL
in	NULL
which	NULL
a	NULL
selection	NULL
process	NULL
led	NULL
to	NULL
structural	NULL
constraints	NULL
both	NULL
at	NULL
the	NULL
combinatorial	NULL
and	NULL
junctional	NULL
diversity	NULL
level	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6357	NULL
u	NULL
100	NULL
60	NULL
<	NULL
INF	NULL
IL2	NULL
o	NULL
*	NULL
f	NULL
-O-	NULL
61	NULL
3	NULL
40	NULL
-O-	NULL
_	NULL
22.28	NULL
G	NULL
-	NULL
eo	NULL
o	NULL
-O-	NULL
_	NULL
2218	NULL
5	NULL
ao	NULL
-	NULL
#	NULL
-	NULL
23	NULL
o	NULL
20	NULL
o	NULL
-v-	NULL
28	NULL
5	NULL
*	NULL
-A-	NULL
-	NULL
22.34	NULL
2	NULL
2	NULL
9	NULL
T	NULL
T	NULL
T	NULL
0	NULL
-	NULL
-	NULL
-	NULL
o	NULL
=a	NULL
-	NULL
.	NULL

-	NULL
o	NULL
3	NULL
C	NULL
3	NULL
C	NULL
Peptide	NULL
concentration	NULL
(	NULL
uM	NULL
)	NULL
FIGURE	NULL
6	NULL
.	NULL

Production	NULL
of	NULL
cytokines	NULL
by	NULL
six	NULL
BZLFl-reactive	NULL
T	NULL
cell	NULL
clones	NULL
representing	NULL
different	NULL
VB	NULL
families	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
were	NULL
stimulated	NULL
with	NULL
peptide-loaded	NULL
M88	NULL
melanoma	NULL
cell	NULL
line	NULL
for	NULL
6	NULL
h	NULL
,	NULL
and	NULL
production	NULL
of	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
was	NULL
assessed	NULL
by	NULL
fluorescent	NULL
intracellular	NULL
labeling	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
positive	NULL
cells	NULL
.	NULL

The	NULL
typical	NULL
experiment	NULL
presented	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
distinct	NULL
tests	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
whether	NULL
the	NULL
different	NULL
stringencies	NULL
of	NULL
constraints	NULL
among	NULL
clones	NULL
were	NULL
correlated	NULL
with	NULL
TCR	NULL
affinities	NULL
by	NULL
evaluating	NULL
their	NULL
CD8	NULL
dependency	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
a	NULL
previous	NULL
study	NULL
from	NULL
Campos-Lima	NULL
et	NULL
al	NULL
.	NULL

(	NULL
7	NULL
)	NULL
suggested	NULL
that	NULL
stringent	NULL
structural	NULL
constraints	NULL
of	NULL
the	NULL
TCR	NULL
imposed	NULL
by	NULL
recognition	NULL
of	NULL
subdominant	NULL
EBV	NULL
epitopes	NULL
were	NULL
linked	NULL
to	NULL
selection	NULL
of	NULL
CD8-independent	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
high	NULL
affinity	NULL
)	NULL
clones	NULL
.	NULL

Our	NULL
data	NULL
do	NULL
not	NULL
support	NULL
such	NULL
a	NULL
strict	NULL
correlation	NULL
between	NULL
structural	NULL
constraints	NULL
and	NULL
TCR	NULL
affinity	NULL
since	NULL
clones	NULL
that	NULL
were	NULL
tightly	NULL
constrained	NULL
,	NULL
such	NULL
as	NULL
A2.3	NULL
and	NULL
A2.8	NULL
,	NULL
turned	NULL
out	NULL
to	NULL
be	NULL
more	NULL
CD8	NULL
dependent	NULL
than	NULL
clones	NULL
V	NULL
B22	NULL
,	NULL
which	NULL
were	NULL
loosely	NULL
con-strained	NULL
.	NULL

We	NULL
would	NULL
rather	NULL
propose	NULL
that	NULL
the	NULL
use	NULL
of	NULL
a	NULL
particular	NULL
VB	NULL
has	NULL
a	NULL
critical	NULL
influence	NULL
on	NULL
TCR	NULL
affinity	NULL
for	NULL
a	NULL
given	NULL
peptide/MHC	NULL
complex	NULL
since	NULL
,	NULL
in	NULL
our	NULL
model	NULL
,	NULL
it	NULL
was	NULL
the	NULL
main	NULL
parameter	NULL
that	NULL
segregated	NULL
with	NULL
CD8	NULL
dependency	NULL
.	NULL

This	NULL
would	NULL
be	NULL
in	NULL
agreement	NULL
with	NULL
recent	NULL
crystallographic	NULL
data	NULL
of	NULL
mouse	NULL
and	NULL
human	NULL
TCR/HLA-pep-tide	NULL
complex	NULL
that	NULL
clearly	NULL
demonstrated	NULL
that	NULL
contribution	NULL
of	NULL
B	NULL
CDRs	NULL
to	NULL
the	NULL
global	NULL
binding	NULL
energy	NULL
is	NULL
variable	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
«	NULL
CDRs	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
murine	NULL
2C	NULL
TCR	NULL
bound	NULL
to	NULL
H-2K*-dEV8	NULL
,	NULL
only	NULL
one	NULL
residue	NULL
of	NULL
the	NULL
peptide	NULL
was	NULL
contacted	NULL
by	NULL
a	NULL
single	NULL
CDR3	NULL
$	NULL
residue	NULL
,	NULL
whereas	NULL
CDR1B	NULL
and	NULL
CDR2	NULL
(	NULL
engaged	NULL
in	NULL
multiple	NULL
contacts	NULL
with	NULL
peptide	NULL
and	NULL
HLA	NULL
residues	NULL
.	NULL

The	NULL
opposite	NULL
situation	NULL
was	NULL
seen	NULL
in	NULL
human	NULL
A6	NULL
and	NULL
B7	NULL
TCR-contacting	NULL
HLA	NULL
A2/Tax	NULL
that	NULL
shared	NULL
the	NULL
same	NULL
VB	NULL
:	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
A6	NULL
TCR	NULL
,	NULL
CDR1	NULL
$	NULL
engaged	NULL
in	NULL
a	NULL
single	NULL
contact	NULL
with	NULL
the	NULL
peptide	NULL
and	NULL
none	NULL
with	NULL
the	NULL
HLA	NULL
,	NULL
CDR2f	NULL
did	NULL
not	NULL
contact	NULL
the	NULL
HLA	NULL
,	NULL
whereas	NULL
its	NULL
CDR3B	NULL
contacted	NULL
four	NULL
peptide	NULL
residues	NULL
and	NULL
one	NULL
HLA	NULL
residue	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
B7	NULL
TCR	NULL
,	NULL
there	NULL
was	NULL
no	NULL
contact	NULL
between	NULL
CDR	NULL
13	NULL
and	NULL
peptide	NULL
or	NULL
HLA	NULL
,	NULL
only	NULL
two	NULL
contacts	NULL
between	NULL
and	NULL
HLA	NULL
,	NULL
but	NULL
three	NULL
peptide	NULL
residues	NULL
contacted	NULL
by	NULL
the	NULL
CDR3	NULL
region	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
there	NULL
seemed	NULL
to	NULL
be	NULL
a	NULL
balance	NULL
between	NULL
the	NULL
contribution	NULL
of	NULL
germline	NULL
B	NULL
CDR1/CDR2	NULL
residues	NULL
and	NULL
CDR3	NULL
#	NULL
residues	NULL
in	NULL
the	NULL
stabilization	NULL
of	NULL
the	NULL
TCR/MHC/peptide	NULL
complex	NULL
.	NULL

We	NULL
therefore	NULL
hypothesize	NULL
that	NULL
VB2	NULL
has	NULL
an	NULL
intrinsically	NULL
weak	NULL
ability	NULL
to	NULL
contact	NULL
the	NULL
B4002/BZLF1	NULL
complex	NULL
that	NULL
was	NULL
compensated	NULL
in	NULL
clones	NULL
using	NULL
this	NULL
VB	NULL
by	NULL
a	NULL
stringent	NULL
selection	NULL
on	NULL
CDR3a	NULL
and	NULL
3	NULL
regions	NULL
,	NULL
whereas	NULL
V	NULL
B22	NULL
usage	NULL
conferred	NULL
a	NULL
higher	NULL
basal	NULL
affinity	NULL
for	NULL
the	NULL
B4002/BZLF1	NULL
complex	NULL
,	NULL
thus	NULL
allowing	NULL
more	NULL
degrees	NULL
of	NULL
freedom	NULL
on	NULL
both	NULL
combinatorial	NULL
and	NULL
junctional	NULL
diversity	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
our	NULL
alanine	NULL
scan	NULL
analysis	NULL
showing	NULL
the	NULL
homogenous	NULL
reactivity	NULL
profiles	NULL
displayed	NULL
by	NULL
V	NULL
B22	NULL
clones	NULL
when	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
V	NULL
B2	NULL
clones	NULL
.	NULL

A	NULL
striking	NULL
finding	NULL
of	NULL
our	NULL
study	NULL
was	NULL
the	NULL
narrow	NULL
range	NULL
of	NULL
MHC/	NULL
peptide	NULL
densities	NULL
required	NULL
to	NULL
trigger	NULL
cytolysis	NULL
in	NULL
our	NULL
in	NULL
vivo	NULL
selected	NULL
clones	NULL
(	NULL
EDs	NULL
,	NULL
between	NULL
9	NULL
and	NULL
36	NULL
nM	NULL
)	NULL
.	NULL

One	NULL
explanation	NULL
would	NULL
be	NULL
that	NULL
a	NULL
selection	NULL
took	NULL
place	NULL
during	NULL
in	NULL
vitro	NULL
expansion	NULL
of	NULL
the	NULL
clones	NULL
that	NULL
resulted	NULL
in	NULL
the	NULL
observed	NULL
range	NULL
of	NULL
reactivities	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
formally	NULL
rule	NULL
out	NULL
this	NULL
hypothesis	NULL
for	NULL
the	NULL
following	NULL
reasons	NULL
:	NULL
first	NULL
,	NULL
clones	NULL
were	NULL
randomly	NULL
obtained	NULL
from	NULL
CD8-	NULL
or	NULL
VB-sorted	NULL
joint-infiltrating	NULL
lymphocytes	NULL
by	NULL
polyclonal	NULL
activation	NULL
with	NULL
mito-gen	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
allogeneic	NULL
feeder	NULL
cells	NULL
,	NULL
and	NULL
we	NULL
have	NULL
documented	NULL
previously	NULL
that	NULL
this	NULL
procedure	NULL
does	NULL
not	NULL
result	NULL
in	NULL
any	NULL
selection	NULL
bias	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
panel	NULL
of	NULL
recovered	NULL
clones	NULL
is	NULL
representative	NULL
of	NULL
that	NULL
selectively	NULL
amplified	NULL
in	NULL
the	NULL
joint	NULL
of	NULL
the	NULL
patient	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
clones	NULL
were	NULL
further	NULL
expanded	NULL
in	NULL
vitro	NULL
by	NULL
rounds	NULL
of	NULL
nonspecific	NULL
(	NULL
mitogen	NULL
)	NULL
stimulations	NULL
and	NULL
not	NULL
by	NULL
specific	NULL
restimulations	NULL
with	NULL
peptide-loaded	NULL
APC	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
EDs	NULL
,	NULL
of	NULL
each	NULL
clone	NULL
was	NULL
remarkably	NULL
constant	NULL
over	NULL
time	NULL
and	NULL
independent	NULL
of	NULL
the	NULL
number	NULL
of	NULL
successive	NULL
restimulations	NULL
.	NULL

Finally	NULL
,	NULL
another	NULL
group	NULL
from	NULL
our	NULL
institute	NULL
has	NULL
used	NULL
the	NULL
same	NULL
procedure	NULL
to	NULL
obtain	NULL
tumor-infiltrating	NULL
lymphocyte	NULL
clones	NULL
,	NULL
and	NULL
in	NULL
their	NULL
case	NULL
they	NULL
obtained	NULL
a	NULL
panel	NULL
of	NULL
clones	NULL
that	NULL
varied	NULL
greatly	NULL
in	NULL
the	NULL
density	NULL
of	NULL
MHC/peptide	NULL
required	NULL
for	NULL
cytotoxicity	NULL
(	NULL
31	NULL
)	NULL
.	NULL

We	NULL
are	NULL
therefore	NULL
confident	NULL
that	NULL
the	NULL
narrow	NULL
range	NULL
of	NULL
reactivities	NULL
that	NULL
we	NULL
observed	NULL
in	NULL
our	NULL
clones	NULL
resulted	NULL
from	NULL
an	NULL
in	NULL
vivo	NULL
selection	NULL
process	NULL
and	NULL
not	NULL
a	NULL
culture	NULL
bias	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
,	NULL
in	NULL
our	NULL
model	NULL
,	NULL
1	NULL
)	NULL
reactive	NULL
clones	NULL
were	NULL
selected	NULL
in	NULL
vivo	NULL
by	NULL
APC	NULL
presenting	NULL
a	NULL
homogenous	NULL
density	NULL
of	NULL
BZLFI	NULL
peptide	NULL
,	NULL
and	NULL
2	NULL
)	NULL
they	NULL
represented	NULL
only	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
repertoire	NULL
potentially	NULL
reactive	NULL
against	NULL
this	NULL
particular	NULL
MHC/peptide	NULL
complex	NULL
.	NULL

Moreover	NULL
,	NULL
since	NULL
we	NULL
have	NULL
found	NULL
persisting	NULL
clones	NULL
of	NULL
both	NULL
weak	NULL
and	NULL
high	NULL
TCR	NULL
affinity	NULL
in	NULL
the	NULL
two	NULL
samples	NULL
taken	NULL
at	NULL
a	NULL
2-yr	NULL
interval	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
high	NULL
TCR	NULL
affinity	NULL
per	NULL
se	NULL
did	NULL
not	NULL
govern	NULL
persistence	NULL
of	NULL
clones	NULL
in	NULL
this	NULL
chronic	NULL
response	NULL
,	NULL
but	NULL
rather	NULL
that	NULL
persisting	NULL
clones	NULL
were	NULL
selected	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
global	NULL
avidity	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
homogenous	NULL
reactivity	NULL
of	NULL
all	NULL
clones	NULL
,	NULL
both	NULL
in	NULL
terms	NULL
of	NULL
cytotoxicity	NULL
and	NULL
lymphokine	NULL
production	NULL
,	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
a	NULL
differential	NULL
level	NULL
of	NULL
CD8	NULL
contribution	NULL
that	NULL
compensated	NULL
for	NULL
differences	NULL
in	NULL
TCR	NULL
af-finities	NULL
.	NULL

This	NULL
homogenous	NULL
reactivity	NULL
is	NULL
not	NULL
a	NULL
specific	NULL
feature	NULL
of	NULL
the	NULL
response	NULL
against	NULL
the	NULL
BZLF1-B4002	NULL
complex	NULL
,	NULL
since	NULL
a	NULL
preliminary	NULL
analysis	NULL
of	NULL
the	NULL
response	NULL
against	NULL
another	NULL
EBV	NULL
peptide	NULL
from	NULL
the	NULL
BMLFI1	NULL
protein	NULL
presented	NULL
by	NULL
HLA-A2	NULL
suggests	NULL
selection	NULL
of	NULL
clones	NULL
with	NULL
a	NULL
restricted	NULL
range	NULL
of	NULL
avidities	NULL
despite	NULL
variable	NULL
contribution	NULL
of	NULL
CD8	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
critical	NULL
parameter	NULL
for	NULL
long-term	NULL
selection	NULL
in	NULL
vivo	NULL
being	NULL
global	NULL
reactivity	NULL
to	NULL
a	NULL
given	NULL
number	NULL
of	NULL
MHC/peptide	NULL
complexes	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
maximal	NULL
CD8	NULL
engagement	NULL
(	NULL
illustrated	NULL
by	NULL
clone	NULL
A13.16	NULL
in	NULL
this	NULL
study	NULL
)	NULL
will	NULL
define	NULL
the	NULL
minimal	NULL
TCR	NULL
affinity	NULL
required	NULL
to	NULL
reach	NULL
the	NULL
avidity	NULL
threshold	NULL
.	NULL

Once	NULL
this	NULL
threshold	NULL
is	NULL
reached	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
TCR	NULL
affinity	NULL
would	NULL
not	NULL
lead	NULL
to	NULL
stronger	NULL
activation	NULL
,	NULL
and	NULL
thus	NULL
clones	NULL
with	NULL
higher	NULL
TCR	NULL
affinities	NULL
would	NULL
have	NULL
no	NULL
selective	NULL
advantage	NULL
.	NULL

This	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
the	NULL
recent	NULL
report	NULL
of	NULL
Busch	NULL
et	NULL
al	NULL
.	NULL

,	NULL
showing	NULL
that	NULL
although	NULL
reactivation	NULL
of	NULL
memory	NULL
T	NULL
cells	NULL
was	NULL
dependent	NULL
on	NULL
appropriate	NULL
Ag	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6358	NULL
reexposure	NULL
,	NULL
the	NULL
extent	NULL
and	NULL
duration	NULL
of	NULL
their	NULL
subsequent	NULL
in	NULL
vivo	NULL
expansion	NULL
were	NULL
independent	NULL
of	NULL
Ag	NULL
quantity	NULL
or	NULL
stability	NULL
(	NULL
32	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
we	NULL
were	NULL
intrigued	NULL
by	NULL
the	NULL
observation	NULL
of	NULL
such	NULL
a	NULL
variable	NULL
contribution	NULL
of	NULL
CD8	NULL
between	NULL
the	NULL
different	NULL
clones	NULL
.	NULL

The	NULL
previous	NULL
report	NULL
from	NULL
Alexander	NULL
et	NULL
al	NULL
.	NULL

suggested	NULL
that	NULL
CD8	NULL
dependency	NULL
was	NULL
relative	NULL
and	NULL
correlated	NULL
exclusively	NULL
with	NULL
the	NULL
amounts	NULL
of	NULL
antigenic	NULL
determinant	NULL
densities	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
that	NULL
at	NULL
low	NULL
MHC/peptide	NULL
den-sity	NULL
,	NULL
presumed	NULL
to	NULL
represent	NULL
physiologic	NULL
conditions	NULL
,	NULL
all	NULL
CTL	NULL
clones	NULL
needed	NULL
at	NULL
least	NULL
partial	NULL
CD8	NULL
interaction	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
in	NULL
discrepancy	NULL
with	NULL
this	NULL
hypothesis	NULL
since	NULL
we	NULL
could	NULL
find	NULL
among	NULL
clones	NULL
selected	NULL
in	NULL
vivo	NULL
,	NULL
one	NULL
clone	NULL
,	NULL
clone	NULL
6.1	NULL
,	NULL
that	NULL
remained	NULL
CD8	NULL
independent	NULL
even	NULL
at	NULL
low	NULL
density	NULL
of	NULL
MHC/peptide	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
this	NULL
clone	NULL
became	NULL
very	NULL
CD8	NULL
dependent	NULL
when	NULL
confronted	NULL
to	NULL
a	NULL
variant	NULL
peptide	NULL
differing	NULL
by	NULL
one	NULL
amino	NULL
acid	NULL
substitution	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
(	NULL
26	NULL
)	NULL
.	NULL

We	NULL
do	NULL
agree	NULL
nevertheless	NULL
that	NULL
inhibition	NULL
by	NULL
anti-CD8	NULL
mAb	NULL
can	NULL
be	NULL
reversed	NULL
by	NULL
high	NULL
doses	NULL
of	NULL
peptide	NULL
in	NULL
CD8-dependent	NULL
clones	NULL
.	NULL

We	NULL
would	NULL
thus	NULL
propose	NULL
that	NULL
the	NULL
level	NULL
of	NULL
CD8	NULL
contribution	NULL
is	NULL
a	NULL
characteristic	NULL
of	NULL
the	NULL
response	NULL
of	NULL
a	NULL
given	NULL
clone	NULL
against	NULL
a	NULL
given	NULL
MHC/peptide	NULL
complex	NULL
.	NULL

Since	NULL
this	NULL
contribution	NULL
resulted	NULL
in	NULL
at	NULL
least	NULL
a	NULL
1000-fold	NULL
increase	NULL
in	NULL
avidity	NULL
in	NULL
clones	NULL
using	NULL
V	NULL
B2	NULL
or	NULL
V	NULL
B13	NULL
,	NULL
we	NULL
wondered	NULL
why	NULL
such	NULL
an	NULL
important	NULL
contribution	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
clones	NULL
using	NULL
V	NULL
B22	NULL
or	NULL
V	NULL
B6	NULL
,	NULL
which	NULL
would	NULL
have	NULL
resulted	NULL
in	NULL
an	NULL
even	NULL
higher	NULL
avidity	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
we	NULL
could	NULL
not	NULL
recover	NULL
such	NULL
clones	NULL
from	NULL
the	NULL
joint	NULL
of	NULL
our	NULL
patient	NULL
suggests	NULL
that	NULL
in	NULL
this	NULL
in	NULL
vivo	NULL
response	NULL
against	NULL
EBV	NULL
,	NULL
there	NULL
was	NULL
a	NULL
ceiling	NULL
of	NULL
maximal	NULL
avidity	NULL
above	NULL
which	NULL
clones	NULL
were	NULL
counter-selected	NULL
.	NULL

This	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
from	NULL
Al-exander-Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
showing	NULL
that	NULL
proliferation	NULL
of	NULL
high	NULL
avidity	NULL
cell	NULL
lines	NULL
was	NULL
inhibited	NULL
by	NULL
high	NULL
ligand	NULL
density	NULL
and	NULL
that	NULL
it	NULL
could	NULL
be	NULL
restored	NULL
by	NULL
blocking	NULL
CD8	NULL
interaction	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
extent	NULL
and	NULL
diversity	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
CTL	NULL
response	NULL
are	NULL
conditioned	NULL
by	NULL
two	NULL
main	NULL
parameters	NULL
:	NULL
1	NULL
)	NULL
the	NULL
permissivity	NULL
of	NULL
the	NULL
selecting	NULL
MHC/peptide	NULL
complex	NULL
that	NULL
will	NULL
determine	NULL
the	NULL
size	NULL
of	NULL
the	NULL
potentially	NULL
reactive	NULL
repertoire	NULL
,	NULL
and	NULL
2	NULL
)	NULL
the	NULL
density	NULL
of	NULL
MHC/peptide	NULL
complex	NULL
presented	NULL
on	NULL
the	NULL
APC	NULL
in	NULL
vivo	NULL
that	NULL
will	NULL
define	NULL
a	NULL
window	NULL
of	NULL
avidity	NULL
.	NULL

The	NULL
coreceptor	NULL
CD8	NULL
by	NULL
its	NULL
variable	NULL
contribution	NULL
to	NULL
the	NULL
stabilization	NULL
of	NULL
the	NULL
TCR/MHC/peptide	NULL
complex	NULL
can	NULL
buffer	NULL
differences	NULL
in	NULL
TCR	NULL
affinities	NULL
to	NULL
maintain	NULL
clones	NULL
within	NULL
this	NULL
window	NULL
of	NULL
avidity	NULL
,	NULL
and	NULL
thus	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
persistence	NULL
of	NULL
the	NULL
response	NULL
diversity	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Zinkernagel	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
C.	NULL
Doherty	NULL
.	NULL

1979	NULL
.	NULL

MHC-restricted	NULL
cytotoxic	NULL
T	NULL
cells	NULL
:	NULL
studies	NULL
on	NULL
the	NULL
biological	NULL
role	NULL
of	NULL
polymorphic	NULL
major	NULL
transplantation	NULL
antigens	NULL
determining	NULL
T-cell	NULL
restriction-specificity	NULL
,	NULL
function	NULL
,	NULL
and	NULL
responsiveness	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

27:51	NULL
.	NULL

2	NULL
.	NULL

Davis	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Bjorkman	NULL
.	NULL

1988	NULL
.	NULL

T-cell	NULL
antigen	NULL
receptor	NULL
genes	NULL
and	NULL
T-cell	NULL
recognition	NULL
.	NULL

[	NULL
Published	NULL
erratum	NULL
appears	NULL
in	NULL
1988	NULL
Nature	NULL
335:744	NULL
.	NULL
]	NULL

Nature	NULL
334:395	NULL
.	NULL

3	NULL
.	NULL

Moss	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
R.	NULL
J.	NULL
Moots	NULL
,	NULL
W.	NULL
M.	NULL
Rosenberg	NULL
,	NULL
J.	NULL
S.	NULL
Rowland	NULL
,	NULL
H.	NULL
C.	NULL
Bodmer	NULL
,	NULL
A.	NULL
J.	NULL
McMichael	NULL
,	NULL
and	NULL
J.	NULL
I	NULL
.	NULL

Bell	NULL
.	NULL

1991	NULL
.	NULL

Extensive	NULL
conservation	NULL
of	NULL
a	NULL
and	NULL
B	NULL
chains	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
recognizing	NULL
HLA-A2	NULL
and	NULL
influenza	NULL
A	NULL
matrix	NULL
peptide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:8987	NULL
.	NULL

4	NULL
.	NULL

Pantaleo	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
F.	NULL
Demarest	NULL
,	NULL
H.	NULL
Soudeyns	NULL
,	NULL
C.	NULL
Graziosi	NULL
,	NULL
F.	NULL
Denis	NULL
,	NULL
J.	NULL
W.	NULL
Adelsberger	NULL
,	NULL
P.	NULL
Borrow	NULL
,	NULL
M.	NULL
S.	NULL
Saag	NULL
,	NULL
G.	NULL
M.	NULL
Shaw	NULL
,	NULL
R.	NULL
P.	NULL
Sekaly	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Major	NULL
expansion	NULL
of	NULL
CD8*	NULL
T	NULL
cells	NULL
with	NULL
a	NULL
predominant	NULL
VB	NULL
usage	NULL
during	NULL
the	NULL
primary	NULL
immune	NULL
response	NULL
to	NULL
HIV	NULL
.	NULL

Nature	NULL
370:463	NULL
.	NULL

5	NULL
.	NULL

Cole	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
T.	NULL
L.	NULL
Hogg	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Woodland	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
MHC	NULL
class	NULL
L-restricted	NULL
T	NULL
cell	NULL
response	NULL
to	NULL
Sendai	NULL
virus	NULL
infection	NULL
in	NULL
C57BL/6	NULL
mice	NULL
:	NULL
a	NULL
single	NULL
immunodominant	NULL
epitope	NULL
elicits	NULL
an	NULL
extremely	NULL
diverse	NULL
repertoire	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6:1767	NULL
.	NULL

6	NULL
.	NULL

Horwitz	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Y.	NULL
Yanagi	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Oldstone	NULL
.	NULL

1994	NULL
.	NULL

T-cell	NULL
receptors	NULL
from	NULL
virus-specific	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
recognizing	NULL
a	NULL
single	NULL
immunodominant	NULL
nine-amino-acid	NULL
viral	NULL
epitope	NULL
show	NULL
marked	NULL
diversity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:352	NULL
.	NULL

7	NULL
.	NULL

Campos	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
V.	NULL
Levitsky	NULL
,	NULL
M.	NULL
P.	NULL
Imreh	NULL
,	NULL
R.	NULL
Gavioli	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Masucci	NULL
.	NULL

1997	NULL
.	NULL

Epitope-dependent	NULL
selection	NULL
of	NULL
highly	NULL
restricted	NULL
or	NULL
diverse	NULL
T	NULL
cell	NULL
receptor	NULL
repertoires	NULL
in	NULL
response	NULL
to	NULL
persistent	NULL
infection	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:83	NULL
.	NULL

8	NULL
.	NULL

Levitsky	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
O.	NULL
de	NULL
Campos-Lima	NULL
,	NULL
T.	NULL
Frisan	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Masucci	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
clonal	NULL
composition	NULL
of	NULL
a	NULL
peptide-specific	NULL
oligoclonal	NULL
CTL	NULL
repertoire	NULL
selected	NULL
in	NULL
response	NULL
to	NULL
persistent	NULL
EBV	NULL
infection	NULL
is	NULL
stable	NULL
over	NULL
time	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:594	NULL
.	NULL

9	NULL
.	NULL

Busch	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
I	NULL
Pilip	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Pamer	NULL
.	NULL

1998	NULL
.	NULL

Evolution	NULL
of	NULL
a	NULL
complex	NULL
T	NULL
cell	NULL
receptor	NULL
repertoire	NULL
during	NULL
primary	NULL
and	NULL
recall	NULL
bacterial	NULL
infection	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:61	NULL
.	NULL

10	NULL
.	NULL

Sourdive	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
K.	NULL
K.	NULL
Murali	NULL
,	NULL
J.	NULL
D.	NULL
Altman	NULL
,	NULL
A.	NULL
J.	NULL
Zajac	NULL
,	NULL
J.	NULL
K.	NULL
Whitmire	NULL
,	NULL
C.	NULL
Pannetier	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
B.	NULL
Evavold	NULL
,	NULL
A.	NULL
Sette	NULL
,	NULL
and	NULL
R.	NULL
Ahmed	NULL
.	NULL

1998	NULL
.	NULL

Conserved	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

AVIDITY	NULL
,	NULL
NOT	NULL
TCR	NULL
AFFINITY	NULL
,	NULL
RULES	NULL
IN	NULL
VIVO	NULL
SELECTION	NULL
OF	NULL
EBV-REACTIVE	NULL
CTL	NULL
T	NULL
cell	NULL
receptor	NULL
repertoire	NULL
in	NULL
primary	NULL
and	NULL
memory	NULL
CD8	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
an	NULL
acute	NULL
viral	NULL
infection	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:71	NULL
.	NULL

David	NULL
Ameline	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Lim	NULL
,	NULL
F.	NULL
Davodeau	NULL
,	NULL
M.	NULL
A.	NULL
Peyrat	NULL
,	NULL
J.	NULL
M.	NULL
Berthelot	NULL
,	NULL
G.	NULL
Semana	NULL
,	NULL
C.	NULL
Pannetier	NULL
,	NULL
J.	NULL
Gaschet	NULL
,	NULL
H.	NULL
Vie	NULL
,	NULL
J	NULL
.	NULL

Even	NULL
,	NULL
and	NULL
M.	NULL
Bonneville	NULL
.	NULL

1996	NULL
.	NULL

Selection	NULL
of	NULL
T	NULL
cells	NULL
reactive	NULL
against	NULL
autologous	NULL
B	NULL
lymphoblastoid	NULL
cells	NULL
during	NULL
chronic	NULL
theumatoid	NULL
arthritis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:4697	NULL
.	NULL

Scotet	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
J.	NULL
David	NULL
,	NULL
M.	NULL
A.	NULL
Peyrat	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Moreau	NULL
,	NULL
D.	NULL
Pinczon	NULL
,	NULL
A.	NULL
Lim	NULL
,	NULL
J	NULL
.	NULL

Even	NULL
,	NULL
G.	NULL
Semana	NULL
,	NULL
J.	NULL
M.	NULL
Berthelot	NULL
,	NULL
R.	NULL
Breathnach	NULL
,	NULL
M.	NULL
Bonneville	NULL
,	NULL
and	NULL
E.	NULL
Houssaint	NULL
.	NULL

1996	NULL
.	NULL

T	NULL
cell	NULL
response	NULL
to	NULL
Epstein-Barr	NULL
virus	NULL
transactivators	NULL
in	NULL
chronic	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1791	NULL
.	NULL

Davodeau	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
A.	NULL
Peyrat	NULL
,	NULL
M.	NULL
M.	NULL
Hallet	NULL
,	NULL
I.	NULL
Houde	NULL
,	NULL
H.	NULL
Vie	NULL
,	NULL
and	NULL
M.	NULL
Bonneville	NULL
.	NULL

1993	NULL
.	NULL

Peripheral	NULL
selection	NULL
of	NULL
antigen	NULL
receptor	NULL
junctional	NULL
features	NULL
in	NULL
a	NULL
major	NULL
human	NULL
78	NULL
subsct	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:804	NULL
.	NULL

Garboczi	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
U.	NULL
Utz	NULL
,	NULL
Q.	NULL
R.	NULL
Fan	NULL
,	NULL
W.	NULL
E.	NULL
Biddison	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Wiley	NULL
.	NULL

1996	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
complex	NULL
between	NULL
human	NULL
T-cell	NULL
receptor	NULL
,	NULL
viral	NULL
peptide	NULL
and	NULL
HLA-A2	NULL
.	NULL

Nature	NULL
384:134	NULL
.	NULL

Garcia	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
M.	NULL
Degano	NULL
,	NULL
R.	NULL
L.	NULL
Stanfield	NULL
,	NULL
A.	NULL
Brunmark	NULL
,	NULL
M.	NULL
R.	NULL
Jackson	NULL
,	NULL
P.	NULL
A.	NULL
Peterson	NULL
,	NULL
L.	NULL
Teyton	NULL
,	NULL
and	NULL
I	NULL
.	NULL

A.	NULL
Wilson	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
f	NULL
T	NULL
cell	NULL
receptor	NULL
structure	NULL
at	NULL
2.5	NULL
A	NULL
and	NULL
its	NULL
orientation	NULL
in	NULL
the	NULL
TCR-MHC	NULL
complex	NULL
.	NULL

Science	NULL
274:209	NULL
.	NULL

Garcia	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
M.	NULL
Degano	NULL
,	NULL
L.	NULL
R.	NULL
Pease	NULL
,	NULL
M.	NULL
Huang	NULL
,	NULL
P.	NULL
A.	NULL
Peterson	NULL
,	NULL
L.	NULL
Teyton	NULL
,	NULL
and	NULL
I	NULL
.	NULL

A.	NULL
Wilson	NULL
.	NULL

1998	NULL
.	NULL

Structural	NULL
basis	NULL
of	NULL
plasticity	NULL
in	NULL
T	NULL
cell	NULL
receptor	NULL
recognition	NULL
of	NULL
a	NULL
self	NULL
peptide-MHC	NULL
antigen	NULL
.	NULL

Science	NULL
279:1166	NULL
.	NULL

Manning	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
C.	NULL
J.	NULL
Schlueter	NULL
,	NULL
T.	NULL
C.	NULL
Brodnicki	NULL
,	NULL
E.	NULL
A.	NULL
Parke	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Speir	NULL
,	NULL
K.	NULL
C.	NULL
Garcia	NULL
,	NULL
L.	NULL
Teyton	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
Wilson	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Kranz	NULL
.	NULL

1998	NULL
.	NULL

Alanine	NULL
scanning	NULL
mutagenesis	NULL
of	NULL
an	NULL
B	NULL
T	NULL
cell	NULL
receptor	NULL
:	NULL
mapping	NULL
the	NULL
energy	NULL
of	NULL
antigen	NULL
recognition	NULL
.	NULL

Immunity	NULL
8:413	NULL
.	NULL

Parker	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
M.	NULL
A.	NULL
Bednarek	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Coligan	NULL
.	NULL

1994	NULL
.	NULL

Scheme	NULL
for	NULL
ranking	NULL
potential	NULL
HLA-A2	NULL
binding	NULL
peptides	NULL
based	NULL
on	NULL
independent	NULL
binding	NULL
of	NULL
individual	NULL
peptide	NULL
side-chains	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:163	NULL
.	NULL

Schodin	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
J.	NULL
Tsomides	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Kranz	NULL
.	NULL

1996	NULL
.	NULL

Correlation	NULL
between	NULL
the	NULL
number	NULL
of	NULL
T	NULL
cell	NULL
receptors	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
TCR-ligand	NULL
affinity	NULL
.	NULL

Immunity	NULL
5:137	NULL
.	NULL

Garcia	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
C.	NULL
A.	NULL
Scott	NULL
,	NULL
A.	NULL
Brunmark	NULL
,	NULL
F.	NULL
R.	NULL
Carbone	NULL
,	NULL
P.	NULL
A.	NULL
Peterson	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
Wilson	NULL
,	NULL
and	NULL
L.	NULL
Teyton	NULL
.	NULL

1996	NULL
.	NULL

CD8	NULL
enhances	NULL
formation	NULL
of	NULL
stable	NULL
T-cell	NULL
receptor/MHC	NULL
class	NULL
I	NULL
molecule	NULL
complexes	NULL
.	NULL

[	NULL
Published	NULL
erratum	NULL
appears	NULL
in	NULL
1997	NULL
Nature	NULL
387:634	NULL
.	NULL
]	NULL

Nature	NULL
384:577	NULL
.	NULL

Gao	NULL
,	NULL
G.	NULL
F.	NULL
,	NULL
J.	NULL
Tormo	NULL
,	NULL
U.	NULL
C.	NULL
Gerth	NULL
,	NULL
J.	NULL
R.	NULL
Wyer	NULL
,	NULL
A.	NULL
J.	NULL
McMichael	NULL
,	NULL
D.	NULL
I.	NULL
Stuart	NULL
,	NULL
J.	NULL
I	NULL
.	NULL

Bell	NULL
,	NULL
E.	NULL
Y.	NULL
Jones	NULL
,	NULL
and	NULL
B.	NULL
K.	NULL
Jakobsen	NULL
.	NULL

1997	NULL
.	NULL

Crystal	NULL
structure	NULL
of	NULL
the	NULL
complex	NULL
between	NULL
human	NULL
CD8a	NULL
(	NULL
a	NULL
)	NULL
and	NULL
HLA-	NULL
AZ	NULL
.	NULL

Nature	NULL
387:630	NULL
.	NULL

Luescher	NULL
,	NULL
I.	NULL
F.	NULL
,	NULL
E.	NULL
Vivier	NULL
,	NULL
A.	NULL
Layer	NULL
,	NULL
J.	NULL
Mahiou	NULL
,	NULL
F.	NULL
Godeau	NULL
,	NULL
B.	NULL
Malissen	NULL
,	NULL
and	NULL
P.	NULL
Romero	NULL
.	NULL

1995	NULL
.	NULL

CD8	NULL
modulation	NULL
of	NULL
T-cell	NULL
antigen	NULL
receptor-ligand	NULL
interactions	NULL
on	NULL
living	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
373:353	NULL
.	NULL

Norment	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
R.	NULL
D.	NULL
Salter	NULL
,	NULL
P.	NULL
Parham	NULL
,	NULL
V.	NULL
H.	NULL
Engelhard	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1988	NULL
.	NULL

Cell-cell	NULL
adhesion	NULL
mediated	NULL
by	NULL
CD8	NULL
and	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
.	NULL

Nature	NULL
336:79	NULL
.	NULL

Al-Ramadi	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
M.	NULL
T.	NULL
Jelonek	NULL
,	NULL
L.	NULL
F.	NULL
Boyd	NULL
,	NULL
D.	NULL
H.	NULL
Margulies	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
Bothwell	NULL
.	NULL

1995	NULL
.	NULL

Lack	NULL
of	NULL
strict	NULL
correlation	NULL
of	NULL
functional	NULL
sensitization	NULL
with	NULL
the	NULL
apparent	NULL
affinity	NULL
of	NULL
MHC/peptide	NULL
complexes	NULL
for	NULL
the	NULL
TCR	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:662	NULL
.	NULL

Alexander	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
C.	NULL
A.	NULL
Damico	NULL
,	NULL
K.	NULL
M.	NULL
Wicties	NULL
,	NULL
T.	NULL
H.	NULL
Hansen	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Connolly	NULL
.	NULL

1991	NULL
.	NULL

Correlation	NULL
between	NULL
CD8	NULL
dependency	NULL
and	NULL
determinant	NULL
density	NULL
using	NULL
peptide-induced	NULL
,	NULL
L-restricted	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:849	NULL
.	NULL

Viola	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Salio	NULL
,	NULL
L.	NULL
Tuosto	NULL
,	NULL
S.	NULL
Linkert	NULL
,	NULL
O.	NULL
Acuto	NULL
,	NULL
and	NULL
A.	NULL
Lanzavecchia	NULL
.	NULL

1997	NULL
.	NULL

Quantitative	NULL
contribution	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
to	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
serial	NULL
trig-gering	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1775	NULL
.	NULL

Busch	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Pamer	NULL
.	NULL

1998	NULL
.	NULL

MHC	NULL
class	NULL
I/peptide	NULL
stability	NULL
:	NULL
implications	NULL
for	NULL
immunodominance	NULL
,	NULL
in	NULL
vitro	NULL
proliferation	NULL
,	NULL
and	NULL
diversity	NULL
of	NULL
responding	NULL
CTL	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:4441	NULL
.	NULL

Steven	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
A.	NULL
M.	NULL
Leese	NULL
,	NULL
N.	NULL
E.	NULL
Annels	NULL
,	NULL
S.	NULL
P.	NULL
Lee	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1996	NULL
.	NULL

Epitope	NULL
focusing	NULL
in	NULL
the	NULL
primary	NULL
cytotoxic	NULL
T	NULL
cell	NULL
response	NULL
to	NULL
Epstein-Barr	NULL
virus	NULL
and	NULL
its	NULL
relationship	NULL
to	NULL
T	NULL
cell	NULL
memory	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1801	NULL
.	NULL

Steven	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
N.	NULL
E.	NULL
Annels	NULL
,	NULL
A.	NULL
Kumar	NULL
,	NULL
A.	NULL
M.	NULL
Leese	NULL
,	NULL
M.	NULL
G.	NULL
Kurilla	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1997	NULL
.	NULL

Immediate	NULL
early	NULL
and	NULL
early	NULL
lytic	NULL
cycle	NULL
proteins	NULL
are	NULL
frequent	NULL
targets	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus-induced	NULL
cytotoxic	NULL
T	NULL
cell	NULL
response	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1605	NULL
.	NULL

Ding	NULL
,	NULL
Y.	NULL
H.	NULL
,	NULL
K.	NULL
J.	NULL
Smith	NULL
,	NULL
D.	NULL
N.	NULL
Garboczi	NULL
,	NULL
U.	NULL
Utz	NULL
,	NULL
W.	NULL
E.	NULL
Biddison	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Wiley	NULL
.	NULL

1998	NULL
.	NULL

Two	NULL
human	NULL
T	NULL
cell	NULL
receptors	NULL
bind	NULL
in	NULL
a	NULL
similar	NULL
diagonal	NULL
mode	NULL
to	NULL
the	NULL
HLA-A2/	NULL
Tax	NULL
peptide	NULL
complex	NULL
using	NULL
different	NULL
TCR	NULL
amino	NULL
acids	NULL
.	NULL

Immunity	NULL
8:403	NULL
.	NULL

Valmori	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
F.	NULL
Fonteneau	NULL
,	NULL
C.	NULL
M.	NULL
Lizana	NULL
,	NULL
N.	NULL
Gervois	NULL
,	NULL
D.	NULL
Lienard	NULL
,	NULL
D.	NULL
Rimoldi	NULL
,	NULL
V.	NULL
Jongeneel	NULL
,	NULL
F.	NULL
Jotereau	NULL
,	NULL
J.	NULL
C.	NULL
Cerottini	NULL
,	NULL
and	NULL
P.	NULL
Romero	NULL
.	NULL

1998	NULL
.	NULL

Enhanced	NULL
generation	NULL
of	NULL
specific	NULL
tumor-reactive	NULL
CTL	NULL
in	NULL
vitro	NULL
by	NULL
selected	NULL
Melan-A/MART-1	NULL
immunodominant	NULL
peptide	NULL
analogues	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:1750	NULL
.	NULL

Busch	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
I.	NULL
M.	NULL
Pilip	NULL
,	NULL
S.	NULL
Vijh	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Pamer	NULL
.	NULL

1998	NULL
.	NULL

Coordinate	NULL
regulation	NULL
of	NULL
complex	NULL
T	NULL
cell	NULL
populations	NULL
responding	NULL
to	NULL
bacterial	NULL
infection	NULL
.	NULL

Immunity	NULL
8:353	NULL
.	NULL

Alexander	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
G.	NULL
R.	NULL
Leggatt	NULL
,	NULL
A.	NULL
Sarin	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Berzofsky	NULL
.	NULL

1996	NULL
.	NULL

Role	NULL
of	NULL
antigen	NULL
,	NULL
CD8	NULL
,	NULL
and	NULL
cytotoxic	NULL
T	NULL
lymphocyte	NULL
(	NULL
CTL	NULL
)	NULL
avidity	NULL
in	NULL
high	NULL
dose	NULL
antigen	NULL
induction	NULL
of	NULL
apoptosis	NULL
of	NULL
effector	NULL
CTL	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:485	NULL
.	NULL

Arden	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
P.	NULL
Clark	NULL
,	NULL
D.	NULL
Kabelitz	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
Mak	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
T-cell	NULL
receptor	NULL
variable	NULL
gene	NULL
segment	NULL
families	NULL
.	NULL

Immunogenetics	NULL
42:455	NULL
.	NULL

Koop	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
L.	NULL
Rowen	NULL
,	NULL
K.	NULL
Wang	NULL
,	NULL
C.	NULL
L.	NULL
Kuo	NULL
,	NULL
D.	NULL
Seto	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lenstra	NULL
,	NULL
S.	NULL
Howard	NULL
,	NULL
W.	NULL
Shan	NULL
,	NULL
P.	NULL
Deshpande	NULL
,	NULL
and	NULL
L.	NULL
Hood	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
receptor	NULL
TCRAC/	NULL
TCRDC	NULL
(	NULL
Ca/Cé	NULL
)	NULL
region	NULL
:	NULL
organization	NULL
,	NULL
sequence	NULL
,	NULL
and	NULL
evolution	NULL
of	NULL
97.6	NULL
kb	NULL
of	NULL
DNA	NULL
.	NULL

Genomics	NULL
19:478	NULL
.	NULL

Rowen	NULL
,	NULL
L.	NULL
,	NULL
B.	NULL
F.	NULL
Koop	NULL
,	NULL
and	NULL
L.	NULL
Hood	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
complete	NULL
685-kilobase	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
B	NULL
T	NULL
cell	NULL
receptor	NULL
locus	NULL
.	NULL

Science	NULL
272:1755	NULL
.	NULL

Jung	NULL
,	NULL
T.	NULL
,	NULL
U.	NULL
Schauer	NULL
,	NULL
C.	NULL
Heusser	NULL
,	NULL
C.	NULL
Neumann	NULL
,	NULL
and	NULL
C.	NULL
Rieger	NULL
.	NULL

1993	NULL
.	NULL

Detection	NULL
of	NULL
intracellular	NULL
cytokines	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
159:197	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

